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Adipose tissue is being considered as having a potential source for Mesenchymal stromal cells 
(MSCs) known as Adipose Derived Stromal Cells (ADSCs). In this work, ADSCs were isolated 
from lipoaspirates of human donors and their multipotentiality characterized by Histology, 
Immunohistochemistry, Real time PCR and Western Blot. 
 
Previous work by Leong TWD had shown that that activating transcription factor 5 (ATF5) 
transcript level is down regulated during osteogenic differentiation of ADSCs. A close family 
member of ATF5, ATF4 is an important regulator of osteogenic differentiation in non-osteogenic 
cell lines. To further understand the role of ATF5 gene, ATF5 was silenced with RNAi and its 
effect on osteocalcin and ATF4 gene expression were measured with real time PCR. To study 
whether ATF4 and 5 are binding partners, HEK 293 cells were co-transfected with ATF4 and 
ATF5 plasmids and visualized with co-immunoprecipitation and immunoblotting. 
 
It was seen that ATF5 silencing increased the expression of osteocalcin majority of donors' 
ADSC populations. However, ATF4 expression was not uniformly elevated in all the donor 
samples. Co-transfection and subsequent co-immunoprecipitation with immunoblotting of cell 
lysates with ATF4 and ATF5 antibodies demonstrated that immunoprecipitation of ATF4 results 
in simultaneous pull down of ATF5 and vice-versa. This it may be presumed that ATF4 might be 
able to interact with ATF5 in vivo. Therefore, ATF5 may have a role during the osteogenic 
differentiation of ADSCs by influencing the expression of osteogenic markers like osteocalcin 







Table 4.1 Primer sequence of genes used for real time PCR 
 
 













































Fig 3.1 Real time PCR for ATF5. Real time PCR done for ATF5 gene in twenty 
donor samples which were analyzed by gene chip expression analysis. A 
consistent drop in ATF5 is seen by the second day in all, but one, of the 
samples studied. (Adapted from PhD Thesis of Leong TWD)  
 
Fig 4.1 Morphology of ADSCs plated on tissue culture plastic. The initial 
morphology which is flat and polygonal (Fig 4.1A) changes to spindle 
shaped on continued culture (Fig 4.1B)   
 
Fig 4.2 Alizarin Red staining of ADSC. The uninduced samples (Fig 4.2A) do not 
take up any stain. Intense foci of mineralization seen in the induced samples 
(Fig 4.2B) 
 
Fig 4.3 Immunohistochemistry of osteogenic markers. Increased expression for the 
respective markers seen in the induced groups (B,D,E,F) compared to the 
uninduced group (A,C,E,G) 
 
Fig 4.4 Oil Red O stain for fat vacuoles. Fat vacuoles could be detected as early as 
day 14 in the induced samples (Fig 4.4A) and increased all the way up to day 
28 (Fig 4.4B)  
 
Fig 4.5 FABP expression in ADSCs following adipogenic induction. The expression 
in day 14 samples (Fig 4.5A) and day 28 samples (Fig 4.5B) were similar in 
pattern, with increased expression seen in the induced samples  
 
Fig 4.6 LPL expression in ADSCs following adipogenic induction. The expression 
in day 14 samples (Fig 4.6A) and day 28 samples (Fig 4.6B) were similar in 
pattern, with a significantly increased expression seen in the induced samples 
 
Fig 4.7 Leptin expression in ADSCs following adipogenic induction at day 28. The 
expressions in day 14 samples were not detectable (data not shown). 
 
Fig 4.8 Osteocalcin expression. The levels of the gene were quite low in the day 14 
samples (Fig 4.8A). However majority of the samples showed a significantly 
increased expression by day 28 (Fig 4.8B)  
 
Fig 4.9 Runx2 expression. The levels of the gene were quite low in the day 14 
induced samples (Fig 4.9A). However, by day 28 a significantly increased 
expression was seen in the induced samples showed a significantly increased 
  
 
Fig 5.4 ATF4 expression normalized to ß-actin. Some of the ADSC samples showed 
an increased expression of ATF4 in the ATF5 silenced groups (arrow headed 
groups in Figs 5.4 A and B). However the significance was not observed 
across all the donor samples (data not shown). 
 
Fig 6.1 Vector map of pcDNA6/His™ A (www.invitrogen.com) 
 




expression by day 28 (Fig 4.9B) 
Fig 4.10 Osteopontin and osteonectin expression. In a few of the samples, the 
expression of osteopontin was much higher at 28 days of induction (Fig 
4.10A) when compared to the day 14 samples. A similar profile was seen 
with osteonectin expression (Fig 4.10B) 
 Fig 4.11 Western blots for osteogenic markers. Osteonectin and osteopontin 
expression (Fig 4.11 A and B) show a variable expression with time. This 
could be due to the fact that they are not very specific markers for 
osteogenesis. Fig 4.11 B1 and B2 show the two different isoforms of 
osteopontin obtained. As a control ß-actin (Fig 4.11 C) and hFOBs cell line 
(Fig 4.11 D) were used 
 
Fig 5.1 ATF4 expression pattern in ADSCs. In three of the ten samples tested, the 
ATF4 expression increased during the second day and dropped drastically by 
the twenty-eight day. This pattern was similar to that seen with hFOBs cell 
lines. The lack of a consistent response in all the ADSC samples may be due 
to the differences in the ‘intrinsic osteogenic potential’ among the cells 
 
Fig 5.2 ATF5 expression normalized to ß-actin. In all the donor samples tested there 
was a decreased expression of ATF5 in the gene silenced groups (Ri + ). The 
time point at which silencing was maximum varied from sample to sample, 
with some having a pronounced response at day 1, while others having at day 
2. (A representative graph of two donor samples are being shown in Fig 5.2 
A and B). 
 
Fig 5.3 Osteocalcin expression normalized to ß-actin. There were significant 
increases in the expression levels of osteocalcin in the gene silenced groups 
at varying time points (Ri + subgroups). All the samples showed increased 
expressions, at different time points, in the sub optimally induced (0.1X Ri +) 
and uninduced (0X Ri +) groups which were gene silenced. The arrow heads 
show the relevant time points at which significant differences were seen.  
 
 
 Fig 6.3 Gel picture of the inserts obtained from PCR. ATF4 (Fig 6.3 A) corresponds 
to the 1050 bp marker, while ATF5 corresponds to 900 bp marker (Fig 6.3 
B). Running the two inserts on the same gel gave a clearer distinction 
between the two (Fig 6.3 C). The one on the left is the ATF4 insert and the 
one on the right is the ATF5 insert. 
 
 
Fig 6.4 Gel picture of the vector after Restriction Enzyme digestion. The uncut 
vector (turquoise box) having a weight of 5200 bp, being supercoiled appears 
to run faster than the cut vector (red box). This is because the linear structure 
of the cut vector impedes its paces through the gel, causing it to appear 
lagging behind the uncut vector.  
 
Fig 6.5 Gel picture of the inserts obtained from colony PCR. ATF4 insert (Fig 6.5 A) 
within the plasmid corresponds to the 1100 bp marker, while ATF5 
corresponds to 950 bp marker (Fig 6.5 B) 
 
Fig 6.6 Anti-His immunoblotting of the HEK lysates. The lysates obtained from 
cotransfected cells (Fig 6.6A) show three distinct bands at molecular weight 
80, 70 and 65 kD. Cell lysates from single transfection with ATF5 (Fig 6.6B) 
show a single band at 65 kD. This can be compared to the lysates from 
untransfected control HEK cells (the areas shaded in the dark blue box) 
where no such bands could be seen.  
 
Fig 6.7 Anti-ATF5 and anti-ATF4 immunoblotting of the HEK lysates. The lysates 
obtained from cotransfected cells show a single prominent band at 65 kD 
when immunoblotted with anti-ATF5 antibody (Fig 6.7 A). Immunoblotting 
of the same blot with anti-ATF4 showed two prominent bands at about the 
same weight (Fig 6.7 B).This is in comparison to untransfected controls 
which do not show any such bands (the area shaded with the dark blue box) 
 
Fig 6.8 IP with anti-ATF4; WB with anti-ATF5. The immunoblotting with anti-
ATF5 showed the presence of two prominent bands. The heavier band was at 
molecular weight of 65 kD, while the lighter one was at around 32 kD.  
 
Fig 6.9 IP with anti-ATF5; WB with anti-ATF4. The immunoblotting with anti-









A variety of clinical conditions require bone regeneration. It has been estimated that 
currently around 20 % of  fractures fail to heal properly (Verettas DA et al., 2002) which 
include  scenarios like non-union, malunion and trauma. Currently the problem that is 
being faced is finding an ideal source for repairing bone tissue. The most widely used 
method for bone reconstruction is autologous graft, but the volume of tissue that can be 
obtained is limited by complications like morbidity, bleeding, infection and chronic pain 
(Kimelman G et al., 2007).  
 
Interest is currently being focused on the use of stem cells and precursor cells for this 
purpose. The two types of stem cells that are being targeted for use in tissue regeneration 
are the Embryonic stem cells and the Adult stem cells. The embryonic stem cells, being 
restricted by ethical issues regarding their use, are being sidelined and focus is shifting to 
their adult counterparts (Yoon E et al., 2007).  
 
One potential reservoir for a good source of multipotent adult stem cells is the adipose 
tissue. Cells isolated from these, known as ADSCs (Adipose Derived Stromal Cells) have 
been shown to possess the property of being multipotent and can give rise to cells types 
of different lineages, including those of the osteogenic lineage (Zuk PA et al., 2002). 
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Compared to the other sources of adult stem cells, these cells are found in large numbers 
and can be easily isolated and propagated in culture.  
ADSCs have been quite well characterized by several groups in both two and three 
dimensional environments (Leong DT et al., 2006; Majumdar MK et al., 2003). In vivo 
experiments with osseous defects have shown their ability to regenerate bone tissue, 
which integrate well with the surrounding bony areas and retain the properties of native 
bone (Cowan CM et al., 2004). ADSCs transfected with recombinant bone morphogenic 
proteins (BMP-2) have shown to have better viability and a greater ability for depositing 
calcific matrices (Dragoo JL et al., 2003).  
 
With widespread application being projected for ADSCs in orthopedic and craniofacial 
bone repairs, a better and clearer understanding of the mechanisms that dictate the 
osteogenic differentiation of ADSCs is required as such an understanding would thus 














2.1 Aim and scope of the thesis 
Differentiation and lineage commitment of precursor cells are regulated by the expression 
and repression of a number of genes. Preliminary transcriptome analysis of ADSCs 
collected from twenty patients in our group (PhD Thesis of Leong TWD) had shown that 
following the process of osteogenic induction, several genes in these cells undergo 
varying folds of expression. Among them, one gene known as ATF5, otherwise known as 
Activating Transcription Factor 5, was found to be consistently down regulated in all the 
twenty donor samples analyzed. This was further validated by real-time PCR analysis of 
mRNA samples from these twenty donors (Fig 3.1). As can be seen in the figure, the 
ATF5 levels drop drastically by the second day of induction in all, but one, of the twenty 
samples.  
        
Fig 2.1 – Real time PCR for ATF5. Real time PCR done for ATF5 gene in twenty donor 
samples which were analyzed by gene chip expression analysis. A consistent drop in ATF5 is 
seen by the second day in all, but one, of the samples studied. (Adapted from PhD Thesis of 
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ATF5 belongs to the family of cAMP binding elements having a leucine zipper motif 
(Hai T et al., 2001). ATF5 has been shown to have a major role in oligodendrocyte 
differentiation and astrocytic maturation of neural precursor cells (Angelastro et al., 
2005) and is seen in very high levels in glioblastoma cell lines. However, no definite role 
of ATF5 in bone formation has been shown to date.  
 
As mentioned earlier, ATF4 levels are elevated in osteoblasts and they induce osteogenic 
expression in non-osteoblast cells (Yang X et al., 2004b), which might imply that this 
transcription factor could have a significant role in non-osteoblast precursor cells like 
ADSCs when they are exposed to osteogenic stimuli. This fact, coupled with our 
observation of a consistent down regulation of its family member, ATF5, during 
osteogenic differentiation of ADSCs prompted us to consider that these two proteins 
maybe interacting with each other in the uninduced, native state of the ADSCs. When 
ADSCs are exposed to an osteogenic stimulus, this interaction might be altered, leading 
to the gene expression pattern that was observed. Members of the ATF family have been 
known to interact with each other and with a host of other transcription factors in forming 
homodimers and heterodimers (Ameri K et al., 2007). It might be possible that ATF5 
down regulation during osteogenic induction in ADSCs could be directly or indirectly 
coupled to ATF4 expression and accumulation in these cells. On the contrary, it might 
equally be possible that ATF5 down regulation during osteogenic induction may be a 




However, we decided to explore the possibility that the reciprocal expression of the two 
proteins might be linked to each other. The hypothesis in this matter was that ATF5 
might be interacting with ATF4 in uninduced native ADSCs, keeping the function of the 
latter protein repressed, and that following osteogenic induction, the ATF5 down 
regulation that we have observed might serve to derepress the functions of ATF4.  
 
As a preliminary step towards understanding these phenomena, we first looked for the 
expression of ATF4 in the same group of ADSCs which showed a consistent down 
regulation of ATF5. Subsequently, ATF5 expression was silenced in ADSCs using RNA 
Interference strategies, and the consequent expression pattern of osteocalcin, a unique 
marker for osteogenic maturation, and ATF4 were seen. In order to find if ATF4 and 
ATF5 have the ability to interact with each other, these two genes were cloned into 
mammalian expression vector (pCDNA6/His™ A vector) and transfected into HEK 293 
cells for protein expression. Co-immunoprecipitation was subsequently done on the cells 
lysates to see if the two proteins were capable of interacting with each other.  
 
2.2 Phase I of the study 
As a preliminary run up to the major study, ADSCs were isolated from the lipoaspirates 
of patients coming to the hospital for cosmetic surgery. These cells were then assessed 
for their differentiation potential by putting them through a round of induction with 
osteogenic and adipogenic induction cocktails. The extents of differentiation were 




2.3 Phase II of the study 
In this phase, a total of ten samples, representative of the group of ADSCs studied by 
Leong TW David, were put through a 28 day induction period and the total RNA isolated 
to analyze the expression pattern of ATF4 gene under osteogenic influences. 
Subsequently ATF5 gene expression were silenced in four ADSC samples, by using 
RNA interference (RNAi) techniques and the expression pattern of ATF4 and one of the 
most specific markers of osteogenesis, osteocalcin were analyzed. This phase would thus 
give an indication as to how the expression patterns of ATF4 and osteocalcin would be 
varying under the conditions of ATF5 repression and osteogenic induction.  
 
2.4 Phase III of the study 
In the final phase of the study, ATF4 and ATF5 genes were cloned in mammalian 
expression vector and transfected into HEK (Human Embryonic Kidney) 293 cell lines. 
Once these cells expressed the two proteins, they were isolated and immunoprecipitation 














BACKGROUND AND LITERATURE REVIEW 
 
The advent of stem cells upon the horizon of modern medicine has opened up a new 
arena for advancing the therapeutic potential of regenerative medicine. The unique  
property of these cells have made them the subject of extensive research, with the hope 
that one day they could be used as a significant source for any type of tissue replacement. 
Though much hope is being placed upon stem cells as the ultimate cure for several 
debilitating illnesses, a profound understanding of the fundamental mechanisms that 
govern their growth and differentiation is needed before their full therapeutic repertoire 
could be exploited.  
 
3. 1. Basic concepts about stem cells  
Stem cells are a population of cells within the body having the unique capability of 
multiplication while at the same time maintaining self renewal and being able to give rise 
to tissues of different lineages when exposed to the right conditions (Grove J et al., 2004; 
Pomerantz J et al., 2004). This ability of stem cells to give rise to a variety of native cell 
types makes them promising candidates for the treatment to chronic ailments like 
Parkinson’s disease, diabetes, stroke and cardiac damage. Presently there are two well 
defined types of stem cells – the embryonic stem cells and the adult stem cells. The 
embryonic stem cells, which are found within inner cell mass of the embryonic 
blastocyst, is by far considered the most appropriate type which fits into the definition of 
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the stem cells. Embryonic stem cells have been shown to be totipotent i.e. having the 
ability to differentiate into virtually any cell within the human body. They can be grown 
in relatively large quantities in culture, which would make it an ideal cell source for cell 
replacement therapies. The versatility of the embryonic stems cells are mired by the fact 
that their multipotency makes them rather unstable, forming tumorous masses when 
grown in vivo. This combined with the ethical issues of procuring these cells from live 
embryos have curbed its popularity as a possible source of stem cells for therapeutic 
purposes. Attention is now being focused on a distinct population of cells which are 
found at various sites in the adult body, known as the adult stem cells. The adult stem cell 
type which has been well characterized and studied is the hematopoetic stem cell (HSC). 
Studies have shown that the HSCs are also multipotent and quite capable of being plastic. 
Another type of adult stem cell which has been in the limelight for quite a while and is 
being extensively studied for cell replacement therapies is the Mesenchymal stem cell 
variably called Mesenchymal stromal cells (MSCs). 
 
3.2. Mesenchymal stromal cells for tissue regeneration 
MSCs are cells of mesodermal origin and have been shown to be undifferentiated while 
at the same time having the ability of self renewal, remarkable proliferation potential and 
ability to differentiate into cell types of mesodermal and non-mesodermal origin 
(Pittenger MF et al., 1999). Although the bone marrow has been traditionally considered 
as the major source for MSCs, they can also be isolated from other sites like the cartilage, 
epithelium etc, albeit, at much lower numbers. The multilineage differentiation potential 
of these cells have been well established and they have been demonstrated to differentiate 
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into cells of both mesodermal and non- mesodermal origin like hepatic , neuronal and 
skeletal muscle types (Ong SY et al., 2006, Krabbe C et al., 2005, Gornostaeva SN et al., 
2006). Banking on the bone marrow as the sole source of MSCs for therapeutic purposes 
has its own limits.  The major drawback is that proportion of MSCs in the bone marrow is 
very low – estimated at around one cell in 18,000 nucleated cells per ml of bone marrow 
(Muschler GF et al., 2001). This number could not be augmented by aspirating more 
bone marrow; as such a procedure would impede some of the other important functions, 
like hematopoesis and granulopoesis, which take place in the bone marrow (Muschler GF 
et al., 2001). The morbidity and complications associated with tapping the bone marrow 
for these cell aspirates have also contributed to the search of alternative sources for adult 
stem cells. 
 
3.3. Adipose tissue as an alternative source of MSCs 
Another important source of MSCs which could be tapped significantly without much 
morbidity to the patient and holds promise in tissue repair and regeneration is the adipose 
tissue. Adipose tissue is a mesoderm derivative and contains a varied stromal population, 
encompassing microvascular endothelial cells and even smooth muscle cells and a type of 
precursor cells called Adipose tissue derived cells (ADSCs) (Zuk PA et al., 2001). These 
cells have variably been known as Processed Lipoaspirate (PLA), adipose tissue derived 
progenitor cells, adipose derived stem cells etc, all denoting a lack of consensus among 
the taxonomists. These cells are isolated from the adipose tissue removed during the 
process of liposuction done for cosmetic purposes and proliferated in large numbers 
under standard conditions of culture (Zuk PA et al., 2001). A significant edge these cells 
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possess over their bone marrow counterparts is their relatively larger proportion in the 
adipose depot.  ADSCs are known to exist in a proportion of around 2 % of the nucleated 
cell population in adipose tissue (Strem BM et al., 2005). With the earlier mentioned 
frequency of precursor cells in bone marrow, a typical bone marrow aspirate would not 
yield more than 2 x 104 MSCs in a mature adult (Muschler GF et al., 2001). This 
contrasts to the estimated frequency of roughly 1 x 106 MSCs obtained from a typical 
harvest of around 200 ml of adipose tissue, obtained during a normal liposuction under 
local anesthesia (Aust L et al., 2004). Thus, the adipose tissue has a phenomenal 
advantage over the bone marrow in terms of the magnitude of available MSCs. Apart 
from this feature, the ADSCs have been shown to possess multilineage differentiation 
potential, with capability of differentiation into multiple lineages (Ashjian PH et al., 
2003; Mizuno et al., 2002). Several groups have shown that when ADSCs are exposed to 
a fixed combination of 1, 25 Dihydroxycholicalciferol, β – glycerophosphate and 
ascorbate (Zuk PA et al., 2002), they begin to express markers of osteogenesis, like 
collagen I, osteocalcin, CBFA -1 and alkaline phosphatase. Under the influence of a 
different induction medium, they begin to express markers of cartilage formation like 
collagen II, aggrecan and SOX 9 (Bernardo ME et al., 2007). 
 
Not only have ADSCs been shown to differentiate into other mesenchymal tissues like 
liver (Talens-Visconti R et al., 2007) and pancreas (Timper K et al., 2006) , but also have 
the capability to cross the lineage barrier and form ectodermal tissues like neurons 




3.4. Characteristics of ADSCs 
The ADSCs are very much similar to their counterparts in the bone marrow in terms of 
phenotypic qualities and expression of certain cell surface markers (Minguell JJ et al., 
2001; Gronthos S et al., 2001). ADSCs also have the property of plastic adherence, which 
forms the basis of the usual method of isolating them. Even then, the populations of 
ADSCs are fairly heterogeneous (Barry FP et al., 2004) and this property alone cannot be 
used for the screening and purification of MSCs. One of the methods to enrich a native 
cell population is to look for surface markers, which when screened in certain fixed 
combinations, could be used as a unique signature for distinct cell populations. The 
ADSCs are uniformly positive for some of the hallmark MSC receptors like STRO -1 and 
CD 166 (Majumdar et al., 2003). The STRO-1 is a marker for undifferentiated MSCs and 
is lost once the cells are committed towards the osteogenic pathway (Bruder SP et al., 
1997), while CD 166 has been postulated to play a significant role in osteogenic 
differentiation (Bruder SP et al., 1998). The ADSCs uniformly expressed HLA- ABC, 
CD 90 (Thy-1), CD 29 (integrin β1) which is an important marker for angiogenic 
potential; CD 49b and CD 49 d, both of which belong to the integrin-α group of 
molecules. These molecules have been best studied in the bone marrow MSCs and when 
occurring in a certain combination over the cell surfaces, they could interact with 
components of the extracellular matrix like fibronectin (α3β1), collagen (α1β1 and 
α2β1),laminin (α6β1 and α6β4) and vitronectin (Verfaillie et al., 1994). In ADSCs too 
they are essential for the development of the extracellular matrix and cell adhesion (Li TS 
et al., 2005; Katz AJ et al., 2005; Strem BM et al., 2005). The function of these receptors 
molecules in MSCs are not just restricted to adhesion; through their interaction with 
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extracellular matrix proteins like laminins, collagen, vitronectin, they play a key role in 
regulate cell proliferation and directing differentiation (Klees RF et al., 2005; Salasznyk 
RM et al., 2004).  
 
Other molecules expressed by ADSCs include, CD 55; CD 59 and CD 105. On the other 
hand they do not express any of the markers of the hematopoetic lineage like CD 45 or 
CD 31 (De Ugarte DA et al., 2003) or other markers of angiogenesis like CD 106 
(VCAM-1), CD 117 (c-kit), CD 133 and ABCG2 and HLA-DR. While this may be true 
of the ADSCs which have been in culture for a while, some groups have shown that 
ADSCs which are freshly harvested from the adipose tissue have an apparently different 
profile. These cells possess the hematopoetic markers like CD 34, CD 133 and ABCG2, 
which decrease after culturing for 3 to 5 days. Others have shown that CD 34 is a marker 
predominantly seen in the mature fraction of the adipocyte population (Festy F et al., 
2005).  
 
ADSCs are similar to the bone marrow MSCs in mediating immunomodulatory effects. 
They have been shown to secrete soluble factors that suppress the proliferation and 
inflammatory cytokine production in T cells and even control the GVHD (Graft versus 
Host Disease) in allogenic bone marrow transplantation in animal models (Yanez R et al., 
2006). They constitutively produce certain cytokines like IL 6, 11, SCF (stem cell factor), 
LIF (leukemia inhibitory factor) M-CSF and G-CSF when grown in normal media, but 
the expression profiles of these cytokines change when grown in the presence of 
substances like dexamethasone (a potent osteogenic inducer) and IL 1 , indicating that the 
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cytokines produced by these stem cells could determine the extent  of differentiation and 
growth potential of them (Haynesworth SE et al., 1996).  
 
3.5. Biological and molecular mechanisms of osteogenic differentiation  
 Bone formation has been thought to occur by lineage specific differentiation of a pool of 
precursor cells, which under the influence of environmental and molecular signals 
commit themselves to this particular lineage (Caplan AI., 1994). These multipotent 
precursor cells were first shown to exist in bone marrow (Pittenger MF et al., 1999), but 
cells with similar properties were identified in the adipose tissue (Zuk PA et al., 2001) 
and have become well established source of cells for bone tissue engineering. Although 
ADSCs are being used extensively for bone regeneration, the molecular mechanisms that 
govern their differentiation towards the osteogenic lineage have not been completely 
elucidated and are just beginning to be unraveled. The earliest evidence indicating the 
probable existence of bone forming cells in adipose tissue came from observing patients 
with the disorder – progressive osseous heteroplasia – a condition in which calcific 
nodules were seen in the subcutaneous tissue (Shore EM et al., 2002) Since then, several 
groups have shown the ability of adipose tissue derived precursor cells to express  
markers of osteogenesis. In the native adipose tissue it has been shown that adipogenic 
differentiation is initiated by two transcription factors, C/EBPß and C/EBPδ. These 
factors activate the expression of PPARγ, which finally drives the preadipocytes into 




Molecular events that converge towards directing the differentiation of ADSCs to the 
osteogenic lineage also decrease their concomitant capacity for adipogenic 
differentiation. Signaling pathways mediated by BMP-2 is such a regulator of 
osteogenesis and exposure to BMP-2 signals represses adipocyte differentiation and 
promotes expression of osteoblast markers in preadipocytes (Skillington J et al., 2002). 
These patterns follow the established norm that the fundamental criteria for a cell’s 
commitment to a particular lineage of maturation is the activation of one set of 
transcription factors and the repression of another set (Black BL et al., 1998; Karsenty G 
et al., 2002).  
 
A proper understanding of some of transcription factors involved in osteogenesis could 
serve as a template for charting out the pathways for similar events in ADSCs. Bone 
formation involves the differentiation of precursor cells towards the formation of 
osteoblasts. The osteoblast is primarily considered at the body’s bone-forming cell and 
differentiation along the osteogenic lineage involves the sequential expression of 
osteoblast-specific markers like osteocalcin (Ducy P et al., 1997), bone sialoprotein 
(BSP) and a variety of non-specific bone matrix proteins like osteopontin, alkaline 
phosphatase etc. (Owen TA et al., 1990). The key transcriptional regulator in osteoblast 
differentiation is the factor called Runx2 which is otherwise known as Cbfa1 (Ducy P et 
al., 1997). Cbfa1/Runx2 are homologs of the Runt family of transcription factors found in 
the Drosophila (Gergen JP et al., 1985)  and is widely considered as the master 
transcription factor mediating osteogenesis (Ducy P et al., 1997) in progenitor stem cells. 
Runx2 knockout mice have been shown to display a complete absence of mineralized 
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bone, while the cartilage formation is not affected (Komori T et al., 1997). The target 
genes for Runx2 are those expressed by the mature osteoblasts namely, osteocalcin, 
osteopontin, BSP and collagen alpha I. Forced expression of Cbfa1 in non-osteoblast 
cells also resulted in the expression of the above markers, all demonstrating the central 
role of this transcription factor (Ducy P., 2000). 
 
One of the most important pathways that has been proven to have a profound effect in 
modulating osteogenesis the one mediated by BMP-2 (Bone Morphogenic Protein-2). 
BMP belongs to the TGF β super family and were initially discovered by the ability of 
bone extracts to ossify tissues in non-osseous sites (Hogan BL., 1996 b). BMPs not only 
influence postnatal bone remodeling, but they have been shown to play a significant role 
in skeletal patterning during the embryonic stage (Hogan BL., 1996 a). BMPs induce the 
formation of both bone and cartilage, thereby placing their possible point of modulation 
on a common skeletogenic precursor cell (J Sodek et al.). BMPs mediate their effects 
broadly through two specific transmembrane receptors, BMP receptor types I and II. 
Following the binding of the ligands to the receptors, they undergo dimerization, 
resulting in activation of the receptor’s intrinsic serine/threonine kinase mechanism, 
which phosphorylates the receptor specific Smads (Chen D et al., 2004). Intracellular 
Smad 1 and Smad 5 then migrate to the nucleus and regulate the transcription of genes 
involved in promoting osteogenesis like Cbfa1/Runx2 (Hanai J et al., 1999) and Dlx5 
(Lee MH et al., 2003) which act directly on downstream target genes like osteocalcin, 
osteonectin and collagen either by itself or, as more recently shown, through a 
downstream regulator like osterix. 
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The exact mechanisms by which osterix regulates osteogenesis is unknown, but it 
functions downstream to Runx2 (Kobayashi T et al., 2005). This transcription factor 
belongs to the Sp gene family, which like other members of this family, contains three 
zinc finger DNA binding domains (Philipsen S et al., 1999). The importance of osterix 
was also shown by the total lack of bones in osterix null mice. Osterix has been thought 
of as factor which acts at the juncture of osteo-chondro pathways and directs precursor 
cells away from chondrogenic and towards the osteogenic lineage (Nakashima K et al., 
2002). Both Runx2 and osterix levels are elevated by BMP-2 treatment, pointing out to a 
region of convergence here (Kobayashi T et al., 2005). BMP-2 alone is not the only 
mediator which affects Runx2 expression. Other factors like FGF (Fibroblastic Growth 
Factor) and TGF-B 1 have been proposed as transcriptional mediators of Runx2 in the 
early stages of cellular commitment to differentiation (Choi KY et al., 2005)  
 
Yet another important regulator of osteogenesis is the action of Vitamin D3. Though 
Vitamin D3 has an effect on increasing the intestinal absorption of both calcium and 
phosphorous, it also has a direct effect on regulating osteogenic transcription, through the 
action of its receptor VDR (Christakos S et al., 2003). This receptor has functional DNA 
binding domain, through which it mediates its action within the cellular nucleus and a 
Ligand binding domain, which binds to other transcription factors like RXR, DRIP, and 
CBP etc. Among them, RXR plays a significant role in promoting VDR accumulation 
within the nucleus and prevents its export from the same (Prufer K et al., 2002). The 
complex of VDR-RXR and other co-factors bind to VDRE (Vitamin D Response 
Elements) on the DNA and trigger transcription of important osteogenic genes like 
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osteocalcin (Price PA et al., 1980) and Cbfa1/Runx2 (Drissi H et al., 2002). Other 
transcription factors which have been demonstrated to have an effect on osteoblast 
differentiation include Msx1, Msx 2, Twist, estrogen and androgens (Kobayashi et al., 
2005). 
 
One particular gene, known as ATF4, has the ability to induce osteogenic gene 
expression among non-osteoblast cells (Yang X et al., 2004a and b), which puts it along 
with Runx2 and osterix as the only other two genes which have so far been shown to 
possess this property (Karsenty G et al., 2002) . ATF4 has been known to regulate the 
terminal differentiation of osteoblasts and its deficiency has been implicated in the 
pathogenesis of Coffin-Lowry syndrome, a condition in which there is mental retardation 
associated with skeletal abnormalities (Yang X et al., 2004a). In osteoblasts, ATF4 is a 
substrate required for the phosphorylation of RSK2 enzyme and deficiency of this 
phosphorylated form of RSK2 has been implicated in Coffin-Lowry syndrome. ATF4, 
also known as cREP2 (c-AMP response element protein 2), RAXREB67 or C/ATF 
belongs to the family of cAMP binding elements having a basic leucine zipper motifs 
(bZIP). They interact with DNA through these domains and have been known to dimerize 
forming homodimers, heterodimers or even both (Hai T et al., 1991). A few other 
members of this large family include ATF1, ATF3, ATF6 and ATF5 (also known as 
ATFX), all of which have similar functions in mediating cellular homeostasis (Hai T et 




ATF4 was initially thought of as being a transcriptional repressor (Karpinski et al., 1992), 
however it also has significant transcriptional activation functions in a variety of tissues. 
Some of the genes that are induced by this transcription factor includes, RANKL and 
Runx2 (Ameri K et al., 2007).Though ATF4 is not a specific transcription factor 
restricted to the osteoblasts, its relevance in bone formation cannot be undermined, as 
targeted disruption of this gene in mice causes osteoporosis and lethal dwarfism (Yang X 
et al., 2004). Like Runx2, ATF4 also binds to promoter region of osteocalcin. While 
Runx2 binds to the OSE 2 element of the promoter, ATF4 binds to a specific cis-acting 
element known as OSE1 to trigger osteocalcin expression (Xiao G et al., 2005). The 
exact roles played by each of these proteins in osteocalcin regulation have not been 
clearly outlined, but it has been shown that ATF4 interacts co-operatively with Rux2 in 
mediating osteocalcin expression.  
 
ATF4 has a ubiquitous genetic expression, being expressed in a variety of tissues like 
brain, kidney, heart, testis etc. and has a significant roles in hematopoesis (Masuoka HC 
et al., 2002) and differentiation in male external genitalia (Fischer C et al., 2004). Though 
the genetic expression of this transcription factor is widespread, the active protein form of 
ATF4 is found only in the mature osteoblasts (Yang X et al., 2004). The specific 
accumulation of ATF4 in osteoblasts has been thought to be due to the absence or 
decreased expression of β-TrCP, an ubiquitin mediated proteasomal pathway, in 
osteoblasts. This pathway functions to prevent the accumulation of this protein in non-
osteoblast cells. In fact silencing of this pathway by RNA interference methods has hown 
the accumulation and ATF4 and osteocalcin in non-osteoblast cells (Yang X et al., 2004).  
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Runx2 has been known to form complexes with several signaling molecules in generating 
osteoblast specific responses. It has been found to interact with other proteins like Rb 
protein and TAZ in inducing osteoblast differentiation (Thomas DM et al., 2004). 
Likewise, Runx2 forms complexes with SMADs in mediating BMP induced osteoblast 
differentiation (Zhang YW et al., 2000). Such an interaction has also been found in the 
case of ATF4 and Runx2. Presence of ATF4 has been shown to enhance Runx2 activity 
and cotransfection studies with these two proteins have shown that they can form 
complexes in vivo (Xiao G et al., 2005).  
 
Thus a variety of transcription factors like Runx2, ATF4 and osteocalcin interact with 
each other through a myriad of mechanisms and complexes to induce the pathways 
















CHARACTERIZATION OF ADSCs IN TWO-DIMENSIONAL CULTURES 
 
4.1 INTRODUCTION  
Several groups have shown that the adipose tissue is an excellent source of progenitor 
cells. Not only are these cells abundant in the adipose tissue, but they too like the bone 
marrow MSCs, posses the property of multipotentiality. They have been shown to be 
capable of being induced along the osteogenic (Zuk et al., 2002), chondrogenic (Zuk PA 
et al., 2002) and even the myogenic lineages (Di Rocco G et al., 2006). The ease of 
availability of adipose tissue as a store house of these cells gives them a unique 
advantage over the bone marrow as a source of cells for the purpose of tissue 
regeneration. The fundamental problem that has been put forward, when using adipose 
tissue as a source for MSCs, is the extent of homogeneity of the progenitor cell 
population. Since they are primarily obtained by aspiration of subcutaneous adipose 
tissue, they could be potentially mixed with a lot of other native cell types like 
endothelial cells, smooth muscle cells etc. This problem has partly been alleviated by the 
property of ADSCs to adhere to a plastic surface. Culture techniques, whereby one plates 
these entire lipoaspirate of cells into a culture flask and selectively culture only the 
adherent population of cells, have shown that this adherent population is indeed the 




In this section the differentiation potential of these ADSCs in the two-dimensional 
environment of tissue culture plastic were studied, so as to establish that the cells 
obtained from the adipose tissue of liposuction samples were truly the progenitor cell 
population. For this purpose the cells were grown up to confluence and were induced 
along both the osteogenic and adipogenic pathway using a set of induction cocktails. In 
the process, their differentiation potential was assayed using histology, real time PCR 
techniques and western blot analysis for lineage specific proteins. 
 
4.2 MATERIALS AND METHODS 
4.2.1 Tissue preparation and culture  
Lipoaspirates were obtained from abdominal regions of healthy adult donors after 
informed consent and approval by the Institutional Review Board, National University 
Hospital, through vacuum pump-assisted liposuction. Following this, the tissues samples 
were processed as per the protocol of Zuk et al. Briefly the tissue samples were first 
broken down manually in a coarse sieve and washed several times in sterile phosphate 
buffered saline (PBS). The washed tissue specimens were then dissociated with 0.075 % 
collagenase type I for 2 hours at 37º C. Following this about 10 ml of DMEM was added 
to the treated tissues, so as to inhibit the action of collagenase. The digested specimen 
was then centrifuged at 1200 x g for 10 minutes to form a cell pellet. The overlying layer 
of fat and debris were removed and the cell pellet was plated onto tissue culture plastic. 
Cultures were washed again after 24 hours to remove the unattached cells and the 
contaminating fat droplets. Plating and expansion media used were Dulbeco’s modified 
Eagle medium (DMEM – Sigma D 1152) supplemented with 10 % Fetal bovine serum 
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(Gibco) and 1% Penicillin – streptomycin (Gibco). Cultures were maintained at 37º C 
with 5% CO2 and replenished twice a week. Once the ADSCs reached confluence of 80 
to 90%, the cells were detached with 0.5 % Trypsin-EDTA (Gibco) and then replated .  
When sufficient cell numbers were attained, they were then evaluated for multilineage 
differentiation potential by driving them towards the osteogenic and adipogenic lineages. 
 
4.2.2 Differentiation into mesenchymal lineages 
4.2.2.a. Osteogenic induction 
For inducing osteogenic differentiation, the cells were grown up to 80 to 90% confluence, 
trypsinised with 0.5 % Trypsin, replated into multiwell plates at a seeding density of 5000 
cells per cm² and treated with osteogenic induction media. The cocktail was composed of 
50 mM L-ascorbic acid-2-phosphate, 10mM b-glycerophosphate and 0.01 mM 1 α, 25 – 
dihydroxycholecalciferol in DMEM medium supplemented with 10% FBS. The induction 
was maintained for a minimum of 2 weeks, following which the cells were assayed for 
evidence of mineralization and osteogenic markers. For alizarin red staining the cells 
were plated in 24-well plates (NUNC), while for the immunohistochemistry the cells 
were plated into 48-well plates (NUNC). T-75 flasks (TPP) were used for plating cells 
required for RNA and protein extraction. 
 
4.2.2.b. Adipogenic Induction  
To induce adipogenesis, the cells were grown up to 80 to 90% confluence, harvested with 
0.5 % Trypsin, replated into multiwell plates at a seeding density of 15,000 cells per 
cm².The cells were treated with an induction cocktail composed of  0.5 mM isobutyl-
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methylxanthine, 1µM dexamethasone, 10µM insulin and 200µM indomethacin in 
DMEM medium supplemented with 10% FBS. The induction was maintained for a 
minimum of 2 weeks, following which the cells were assayed for evidence of 
adipogenesis.  
 
4.2.3 Histochemistry  
4.2.3.a. Alizarin Red staining  
The cells were cultured in 24 well plates for 28 days and analyzed at day 14 and day 28. 
Prior to fixation, the samples were washed twice in PBS. Following fixation for 10 
minutes with 10% buffered formalin, the cells were treated with Alizarin Red S working 
solution. The working solution was prepared by dissolving 2 g of Alizarin Red S powder 
in 100ml of distilled water. The pH of the working solution was then adjusted to 4.1 with 
0.5% ammonium hydroxide. The wells were completely covered with the stain and left to 
stand for a period of 5 minutes. Subsequently the samples were washed with distilled 
water and observed under the microscope for presence of calcific nodules.  
 
4.2.3.b. Oil Red O staining  
The cells were cultured in 24 well plates for 28 days. The samples were washed with 
PBS, fixed with 10% neutral buffered formalin and then stained with working solution of 
0.2% Oil Red O stain for 5 minutes. The excess stain was washed with deionized water 
and the nuclei counterstained with hematoxylin solution and observed under the 




4.2.4 Immunohistochemistry  
Cells were seeded into 24 well plates at a density of 5000 cells per cm² and grown for 
period of 28 days in osteogenic induction media. As control, plain media without 
induction factors were used. The cells were analyzed at day 14 and day 28.  
For immunostaining the cells were fixed with ice cold methanol at -20ºC for 10 minutes. 
Non-specific antibody binding sites were blocked with 10 % goat serum at 25º C for 30 
minutes. Subsequently the goat serum was removed and primary immunostaining was 
done for osteonectin, osteocalcin, collagen I and osteopontin by incubating at 4º C 
overnight (16 hours). Primary antibodies were used at the following concentration: 
 
Rabbit anti human Collagen type 1 (Chemicon AB0745) - 1:500   
Rabbit anti human Osteopontin (Chemicon AB1870) - 1:500  
Rabbit anti human Osteonectin (Chemicon AB1858) - 1:1000 
Rabbit anti human Osteocalcin (Chemicon AB1857 ) - 1:500 
 
Secondary antibody staining was performed with the HRP-conjugated anti-rabbit kit 
(DAKO Cytomation). The controls were blank specimens which were treated only with 
the antibody diluent, with no primary antibody being used. Immunostained specimens 
were counterstained with hematoxylin stain. All antibody dilution used were optimized 
earlier using Human fetal Osteoblast cell line as positive control and Human embryonic 





4.2.5 RNA isolation and Real-time PCR analysis of ADSCs 
Cells were plated in 6 well plates in triplicates and grown in the presence of adipogenic 
or osteogenic induction media. Total RNA was harvested at time points 14 days and 28 
days from these cells using RNAeasy Kit (Qiagen). The concentration of the total RNA 
was measured with Nanodrop ND-100 spectrophotometer and stored at -80º C till further 
use. 
 
4.2.5.a. Reverse Transcription  
The purified total RNA obtained from the previous step was reverse transcribed into 
cDNA, using was done using RevertAid™ H-Minus MuLV Reverse Transcriptase 
enzyme (Fermentas). Briefly, about 100ng of total RNA was mixed with 800ng of 
oligodT (Proligo) and heated to 75º C for 8 minutes and chilled immediately on ice. A 
reaction mixture containing 1.0mM of dNTP, 20U of Ribolock™ Ribonuclease Inhibitor 
(Fermentas), 200U of RevertAid™ H-Minus MuLV Reverse Transcriptase enzyme and 
DEPC-treated water was added to the chilled mixture and incubated at 37º C for 1 hour. 
At the end, the enzyme was inactivated by heating at 70º C for 10 minutes. The samples 









4.2.5.b. Quantitative Real Time PCR 
 The Quantitative Real-time polymerase chain reaction was done on Stratagene MX 
3000P Real time PCR machine. Along with the cDNA samples, serial dilutions of the 
standards and non-template controls (NTC) were used for the PCR reactions. Quantitec 
SYBR™ Green PCR kit was used as the master mix for the real time PCR reactions.  
Thermal cycling conditions for the reactions were: 95oC for 10 minutes, 45 cycles of 
94oC for 30 seconds, 60oC for 45 seconds and 72oC for 30 seconds. The dissociation 
phase was carried out at 95oC for1 second, 60oC for 30 seconds, slow ramp up to 95oC at 
0.5oC per second with continuous measurement, 95oC for 10 seconds and finally brought 
















Adipogenic Genes Primer Sequence 




Lipoprotein Lipase ( LPL) 5’-CCGGTTTATCAACTGGATGG-3’ 
5’-TGGATCGAGGCCAGTAATTC-3’ 
Osteogenic Genes Primer Sequence 
Osteocalcin 5’-TGTGGCATCCACGAAACTAC-3’   
5’-GGAGCAATGATCTTGATCTTCA-3’ 















4.2.5.c Standard Preparation 
The standards for real time PCR was prepared from the products of an end point PCR. 
Using the above primers, the amplified PCR products of an end point PCR was run on a 
2% agarose gel. The bands on the gel were visualized under UV light, the amplified 
products cut from the gel and purified using a silica column based DNA extraction kit 
(vCell Science) as per the manufacturer’s protocols. The DNA was eluted from the silica 
column and the quantity of the recovered DNA measured on a Nanodrop ND-1000 
spectrophotometer. The copy numbers of the gene in this given volume could be 
calculated using the combination of DNA concentration, molecular weight of the 




nN    - number of each dNTP expected in PCR product. 
MN   - molecular weight of each mole of dNTP  
mass  - mass of PCR product quantified from spectroscopy. 
Av  - Avagadro’s constant = 6.02x1023    
For each set of genes tested, the samples were run in triplicates and the data was analyzed 







4.2.6 Western Blot Analysis for Osteogenic proteins 
Cells were plated into 6 well plates and grown in the presence of osteogenic medium for 
at total period of 28 days. Uninduced samples were used as the control. Following 
induction, the cells were harvested at 14 days and 28 days. The cells were lysed in Triple 
detergent lysis buffer with added Protease Inhibitor (Sigma). The buffer’s components 
were: 
 50mM Tris-HCl (pH 8.0) 
 150mM NaCl 
0.1 % SDS 
1 % NP – 40  
0.5 % w/v sodium deoxycholate 
Subsequently, the lysed specimen was centrifuged at 14,000 rpm for 20 minutes and the 
supernatant collected. To concentrate the protein samples, they were loaded onto 
Nanosep™ Centrifuge tubes (Pall Inc.) and desalted using distilled water. The total 
protein extracted was quantified using a micro BCA kit (Pierce). 
 
Following this, about 50 µg of the protein samples were treated with 6 X loading at 90º C 
for about 10 minutes and loaded onto a 10% SDS gel along with Dual color Protein 
ladder (Bio-Rad). The loaded gel was run at 150 V till the dye front was washed away 
from the edge of the gel plate. The gel was subsequently transferred onto a PVDF 
membrane, using transfer parameters of 90 V and 600mA for about 1 hour. The transfer 




For all samples, the blots were blocked with 1% milk for half an hour at room 
temperature and incubation with the primary antibody was carried at 4º C, overnight (16 
hours).  The primary antibody concentrations used were: 
 
Rabbit anti human Osteopontin (Abcam, Ab8448)  - 1:1,000  
Rabbit anti human Osteonectin (Santacruz,  SC25574) - 1:1,000 
Rabbit anti human Osteocalcin (Santacruz,  SC30044) - 1:1,000 
Rabbit anti human β-actin (Delta Biolabs,  DB070)  - 1:2,000  
 
The secondary antibody treatment was done with anti-Rabbit antibody conjugated to 
HRP (Horse radish preoxidase) enzyme, raised in goat (Zymed, 62-6120) and was used at 
a concentration of 1:15,000. The blots were subsequently treated with Luminol HRP 















4.3.1 ADSC morphology 
Freshly plated ADSCs demonstrated varying morphology. Initially the ADSCs had a 
polygonal morphology (Fig 4.1A). After 3 weeks of culture, the morphology changed and 
the cells became predominantly spindle shaped (Fig 4.1B). Thus it could be said that the 
freshly acquired ADSCs constitute a population of heterogeneous cells, which change 









Fig 4.1 - Morphology of ADSCs plated on tissue culture plastic. The initial 
morphology which was flat and polygonal (Fig 4.1A) changed to spindle shaped on 










4.3.2 Histological evidence of osteogenesis  
Alizarin Red staining of the ADSCs grown in osteogenic media revealed foci of 
mineralization (Fig 4.2B, the areas stained in dark red), when compared to the control 









Fig 4.2 - Alizarin Red staining of ADSC. The uninduced samples (Fig 4.2A) do not take 
up any stain. Intense foci of mineralization seen in the induced samples (Fig 4.2B) 
 
4.3.3 Immunohistochemistry for osteogenic makers 
Immunostaining showed that ADSCs expressed markers of osteogenesis like collagen I, 
osteocalcin, osteonectin and osteopontin as early as 14 days after induction and by 28 
days there was marked expression of the same (Fig 4.3B,D,F,H). Control samples, which 































Fig 4.3-Immunohistochemistry of osteogenic markers at 28 days. Increased expression for the 









4.3.4 Adipogenic potential of the ADSCs 
When ADSCs are grown in adipogenic media, they began forming lipid droplets after 2 
weeks of induction (Fig 4.4A) and increased significantly by day 28 (Fig 4.4B). 
Uninduced ADSCs did not form lipid droplets by this time (figures not shown), 
demonstrating that the ADSCs retained their adipogenic potential and when given the 








Fig 4.4 - Oil Red O stain for fat vacuoles. Fat vacuoles could be detected as early as 
day 14 in the induced samples (Fig 4.4A) and increased all the way upto day 28 (Fig 
4.4B)  
 
4.3.5 Real time-PCR analysis of gene expression  
4.3.5.a Adipogenic Genes 
Real time PCR analysis of the total RNA extracted from ADSCs subjected to adipogenic 
induction revealed that these populations of cells retained their native potential and were 
capable of differentiation into adipocytes under the influence of adipogenic stimuli. 
Compared to the uninduced control samples, the induced samples were the only ones 




adipogenesis were: Fatty acid binding protein (FABP), Leptin and Lipoprotein Lipase 
(LPL).  
4.3.5.b FABP expression 
All the three ADSC samples showed increased expression of FABP gene in the induced 


















Fig 4.5 - FABP expression in ADSCs following adipogenic induction. The expression in day 
14 samples (Fig 4.5A) and day 28 samples (Fig 4.5B) were similar in pattern, with increased 
expression seen in the induced samples.  




















































4.3.5.c LPL Expression  
Similar to the expression pattern seen with FABP gene, LPL expression was also found 
to be more in the induced samples, with hardly any expression seen in the uninduced. The 
gene copies in the day 28 samples were much higher, when compared to the same in the 

















Fig 4.6 – LPL expression in ADSCs following adipogenic induction. The expression 
in day 14 samples (Fig 4.6A) and day 28 samples (Fig 4.6B) were similar in pattern, with 
a significantly increased expression seen in the induced samples  
 


















































4.3.5.d Leptin Expression  
The leptin expression pattern was different from the above two. Leptin expression was 
not seen in the day 14 samples in both the induced and uninduced groups (data not 
shown). However expression was seen in the day 28 samples (Fig 4.7). There was 
significant difference in the expression levels between the induced and uninduced 










Fig 4.7 – Leptin expression in ADSCs following adipogenic induction at day 28. The 

































4.3.6 Osteogenic Genes 
Real time PCR analysis of the total RNA of the ADSCs after osteogenic induction 
showed that these population of cells were able to express markers of osteogenesis to 
varying extents.  
 
4.3.6.a Osteocalcin expression  
Osteocalcin has been considered as one of the most specific markers for osteogenic 
differentiation (Ducy P et al., 2000). In the day 14 samples tested, the levels of 
osteocalcin in the osteo-induced ADSC samples were found to be much lower than that 
of the induced (Fig 4.8A). However, by day 28 the exact opposite pattern was seen (Fig 
4.8B). By 28 days of induction, the osteo-induced ADSCs showed a significantly higher 






































Fig 4.8 – Osteocalcin expression. The levels of the gene were quite low in the day 14 
samples (Fig 4.8A). However majority of the samples showed a significantly increased 























































4.3.6.b Runx2 expression  
Runx2 expression pattern were similar to that seen in osteocalcin. While in the day 14 
samples, the expression of the gene was very low (Fig 2.9A), by 28 days of induction the 
induced samples started showing significantly higher levels of expression, when 



















Fig 4.9 – Runx2 expression. The levels of the gene were quite low in the day 14 induced 
samples (Fig 4.9A). However, by day 28 a significantly increased expression was seen in 
the induced samples showed a significantly increased expression by day 28 (Fig 4.9B)  
 



















































4.3.6.c Osteopontin and Osteonectin expression  
The expression of these non-specific osteogenic markers were highly variable, with some 
of the induced samples having a much lower levels of expression when compared to the 
uninduced samples (data not shown). However by day 28, the samples showed a much 
higher level of expression of osteopontin (Fig 4.10A) and osteonectin (Fig 4.10B) when 
















Fig 4.10 – Osteopontin and osteonectin expression. In a few of the samples, the 
expression of osteopontin was much higher at 28 days of induction (Fig 4.10A) when 























































































4.3.7 Western blot for osteogenic markers 
Western blot was done for osteonectin (Fig 4.11A), osteopontin (Fig 4.11B) and ß-actin 
(Fig 4.11C) proteins in all of the samples. A few of them showed an increasing trend in 
protein production from day 0 to day 28. However, this phenomenon could not be 
uniformly seen in all the samples. In some of the samples these proteins could be detected 
as early as day 0. Western blots were also done for osteocalcin protein, but due to 
inconsistencies in the molecular weight of the protein obtained, the data has not been 
shown. Osteonectin was seen at a molecular weight of 44 kD. Osteopontin has been to 
know have two major isoforms; they were detected at 35 kD and 65 kD.  
Positive controls used for the experiments were hFOBs (human Foetal Osteoblast cell 
lines)  
                                      ADSC 1                           ADSC 2                             ADSC 3  
Osteonectin     
           44kD     
                           D28      D14       D0           D28      D14       D0           D28      D14       D0 
 
Osteopontin 
           35 kD 
                               D28      D14      D0         D28      D14       D0          D28      D14       D0   
  
           65 kD 
                              D28      D14      D0         D28      D14       D0          D28      D14       D0 







             42 kD            
                              D28      D14      D0          D28      D14       D0          D28      D14       D0 
 
Control (hFOBs cell line)  
 
      
                                Osteopontin         Osteonectin           ß-actin  
 
Fig 4.11 – Western blots for osteogenic markers. Osteonectin and osteopontin 
expression (Fig 4.11 A and B) show a variable expression with time. Fig 4.11 B1 and B2 
show the two different isoforms of osteopontin obtained. As a control ß-actin (Fig 4.11 




Adipose tissue is currently being researched as an excellent source of precursor cells for 
the purpose of tissue regeneration. Though it is quite often thought of as a heterogeneous 
cell population, it is still possible to isolate precursor cells with multilineage 
differentiation potential. From the initial analysis of the basic characteristics of the cells 
isolated from the lipoaspirates, it could be said that these population of cells indeed 
possess precursor cell like properties.  
The cells when plated initially possessed a polygonal morphology, but with progression 
of culture and passages they tend to acquire a spindle shape. This is in accordance with 






These cells when exposed to osteogenic induction cocktail tend to exhibit the property of 
lineage commitment. Under the influence of these factors, the cell began to exhibit light 
microscopic features of mineralization. Alizarin red stain revealed foci of calcific nodules 
in the induced samples, whereas no such foci were seen in the uninduced ones (Fig 1.1). 
Similarly, immunohistochemistry for bone markers like osteocalcin, osteonectin and 
osteopontin revealed that the induced cells showed a considerably greater expression of 
these when compared to the uninduced.  
 
To corroborate these findings, the real time PCR analysis done on ADSCs showed that 
those groups exposed to osteogenic cocktail tend to express a higher level of markers like 
osteocalcin and Runx2, although from these experiments the same could not be said of 
the other two markers, osteopontin and osteonectin. 
 
Osteocalcin has been considered as an important and specific marker for osteogenic 
lineage commitment (Ducy P. et al., 2000). It is one of the most abundant of the non-
collagenous proteins in bone, having calcium binding properties (Hauschka, P et al., 
1989). The major role of this protein is in preventing excessive calcium deposition in 
bone and is therefore considered a negative regulator of mineralization (Ducy P. et al., 
2000). However, it is a very specific marker for osteogenic differentiation and is highly 
expressed during the early stages and the much later stages of bone formation. Similarly, 
Rux2, which is quite often considered the “master switch” triggering osteogenesis, is also 
a very specific marker for this process and acts upstream of osteocalcin (Banerjee C et 
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al., 1997). Not all the six samples in this study were able to express significant amounts 
of these proteins.  
Osteopontin and osteonectin have been traditionally considered as markers of 
osteogenesis, though by themselves, they are not very specific for osteogenesis as 
compared to osteocalcin or Runx2 (Dragoo JL et al., 2003 ; Ogawa R et al., 2004 ; Rodan 
GA et al., 1999 ; Heinegård D et al., 1989). Osteopontin is a highly acidic protein that is 
predominantly expressed in the early stages of bone formation, but can be found in a host 
of other tissues (Butler WT., 1989). There are two major isoforms of this protein. We 
were able to detect the two isoforms at 65 kD and 35 kD. Osteonectin also enjoys a 
similar profile and is found during the early stages of bone formation, where it plays a 
role in nucleation of the apatite crystals (Fujisawa R. et al., 1991).  
 
The above results show considerable variation in the expression pattern of different genes 
and proteins over the period of study. Runx2 and osteocalcin expression was fairly steady 
and constant across the experimental groups, with 4 out of 6 samples showing an elevated 
expression of these markers in the induced group. However, such a profile was not seen 
in the expression pattern of osteopontin or osteonectin. Similar variations in gene 
expression patterns have been previously reported in a variety of other studies involving 
human bone marrow MSCs. Work done by Frank O. et al., showed that the expression  of 
osteogenic markers like alkaline phosphatase, osteocalcin , cbfa1 (i.e. Runx2) by bone 
marrow MSCs exposed to osteogenic induction stimuli were inconsistent across samples 
(Frank O et al., 2002). Such variation have been reported by other groups working on 
bone marrow MSCs (Jaiswal N et al., 1997) and most recently shown in human bone 
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marrow MSCs of around 19 different donors across varying age groups (Siddappa  R et 
al., 2007).  
Several reasons could lie such variations, such as differences in the composition of the 
initial aspirate and population of the precursor cells, differential sampling techniques by 
physicians which could result in cell populations of varying heterogeneity, functional 
differences in the osteogenic potential of the MSCs and even the physiological status of 
the patients from whom the samples were isolated (Siddappa R et al., 2007). Such an 
inter donor variability could also be operational when ADSCs are collected and 
characterized. Thus, the osteogenic potential of one set of ADSCs might be different 
from another.  The protein expression patterns of osteopontin and osteonectin were 
studied and were also found to be highly variable. While in a few samples there was a 
consistently increasing expression pattern from day 0 to day 28 induced groups, a few of 
the samples showed a constant expression pattern from the beginning itself. This again, 
could be attributed to sample variability and also the relative non-specificity of these two 
markers in osteogenesis.  
Osteogenic differentiation of ADSCs is an area of research which is being extensively 
pursued in several labs. On the one hand the intricate molecular mechanisms that governs 
this process in ADSCs is being evaluated (Luzi E et al., 2008), while on the other hand 








From this study, it was possible to isolate an adherent population of cells (ADSCs) from 
the lipoaspirate of donors. These cells are have the ability to differentiate into two 
different lineages and could therefore be considered as being multipotent. These ADSCs 
showed evidence of osteogenesis when exposed to osteogenic stimuli.  
Histology and immunohistochemistry showed evidence of osteogenesis like calcific 
nodules and extracellular matrix deposits respectively. These findings were corroborated 
by similar results with real time PCR and western blot analysis. However, the results of 
real time and western blots were not uniform across all the donor samples.  
 
Therefore, ADSCs obtained from the adipose tissue could be considered as a sizeable 




















ADSCs are presently being investigated as candidate cells for use in bone tissue 
regeneration, but the events that dictate the process of osteogenic differentiation in these 
cells are far from being precisely outlined. A proper understanding of the mechanisms 
that govern the process of osteogenesis in bone cells would give us an insight into how 
similar events occur in non-osteogenic precursor cells. The principle factors that govern 
osteogenic differentiation of precursor cells are Cbfa1 / Runx-2 (Ducy P et al., 1997).This 
transcription factor regulates the activation of lineage specific markers like osteocalcin, 
osteopontin and collagen I (Ducy P., 2000) While much of the work done has been on 
osteoblast cells, the factors that govern similar fates in non-osteogenic precursor cells 
have not been clearly elucidated.  Literature is abounding with evidence of induction 
factors being capable of driving non-osteoblast precursor cells towards the osteogenic 
lineage. Zuk PA et al. have shown the ability of adipose tissue stromal cells to 
differentiate towards osteogenic lineage under the influence of a cocktail of chemical 
substances. Osteogenic differentiation has been demonstrated in hematopoetic precursor 
cells (Kondo M et al., 2003) and in mesenchymal precursor cells isolated from the 




Work done by Yang et al has demonstrated the existence of a unique transcription factor, 
Activating transcription factor 4 (ATF4), which can induce the expression of the 
osteoblast-specific gene, osteocalcin, in non-osteoblast cell lines in vitro. They were able 
to show that ATF4 accumulation in osteoblasts is mediated by a post-translational 
ubiquitination process, which normally degrades this factor in other cell lines. 
Subsequently it was shown that ATF4 indeed interacts with the master transcription 
factor, Cbfa1/ Rux2 through its leucine zipper domain to stimulate osteocalcin expression 
(Xiao G et al., 2005). Non-osteoblast cell lines which were co-expressed with ATF4 and 
Runx2 demonstrated an increased osteocalcin mRNA expression. Therefore, it might be 
possible that this transcription factor might play a significant role in ADSCs as well. 
 
The whole genome transcriptome analysis of ADSCs (PhD work of Leong TWD) done in 
our lab, had shown that when these cells are exposed to osteogenic stimuli, several genes 
undergo a variable fold change. A total of twenty patient samples were put through the 
process of osteogenic induction and the gene expression was performed using Affymetrix 
Gene chips. Looking for genes that underwent a significant fold change in expression 
revealed that one particular gene, ATF5 was consistently down regulated in nineteen out 
of the twenty samples analyzed. ATF5, properly known as Activating Transcription 
Factor 5, belongs to the family of cAMP binding elements having a leucine zipper motif 
(Hai T et al., 2001).  
 
The consistent down regulation of this gene in ADSCs observed from the gene chip data, 
was further validated by using real time PCR (PhD thesis of Leong TWD). These data 
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indicate that ATF5 could possibly have a role during osteogenic differentiation in 
ADSCs, whereby suppression of ATF5 is a necessary or accompanying event during 
osteogenic differentiation. It might be hypothesized that ATF5 acts to repress osteogenic 
differentiation in ADSCs and exposure to an osteo-induction cocktail, circumvents this 
repression to bring about commitment towards the osteogenic lineage. A similar role for 
ATF5 has been proven by Angelastro JM et al (2005) in neural precursor cells, where it 
was shown that a down regulation of ATF5 is a prerequisite for the maturation of these 
cells into astrocytes and oligodendrocytes. 
 
As a continuation of this work, we analyzed the expression of ATF4 gene, which as 
previously mentioned, is an important regulator of osteogenic differentiation in non-
osteoblast cell types. Ten of the ADSC samples in the above study were put through a 28 
day osteoinduction period and the RNA isolated for ATF4 expression analysis. 
  
A primary step towards understanding the observed phenomenon of a consistent down 
regulation of the ATF5 gene would be to see how the process of osteogenesis in ADSCs 
would be affected when ATF5 gene is not expressed. If ATF5 expression does affect 
osteogenesis, when the expression of this gene is repressed, one would see a reciprocal 
expression of the classical markers of osteogenesis. Gene silencing of ATF5 should be 
able to trigger or derepress downstream events which are under the influence of ATF5. In 
order to do study this, we decided to block the mRNA expression of ATF5 in ADSCs by 
specific small interference RNA (siRNA) sequences to ATF5, delivered to the cells using 
lipophilic carriers.  
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RNA interference, otherwise known as RNAi, is a naturally occurring phenomenon 
which is an effective form of post-translational sequence specific gene suppression (Fire 
A et al., 1998). In nature, RNA interference is mediated by short double-stranded RNA 
molecules which are processed into 20 to 23 base long RNAs called siRNAs , and then 
form part of the RNA-induced silencing complex (RISC) triggering a nuclease that 
degrades the target RNA (Kurreck J., 2003).  In vivo, this type of gene silencing is highly 
specific for the target mRNA sequences, with minimal off-target effects seen (Chi JT et 
al., 2003); however some sequences may have diverse and unwarranted effects. 
Commercially available siRNA sequences used for gene silencing have been chosen after 
a stringent evaluation of several target sites within a particular gene, following which the 
sequences that require that lowest concentration for gene silencing and having minimal 
off-target effects are selected (Vickers TA et al., 2003). Some of them have been 
chemically modified by introducing synthetic nucleotides, so as to stabilize their structure 
and function in cell culture and in vivo (Amarzguioui M et al., 2003). RNAi technology 
is also being widely experimented as a form of nucleic acid-based therapies, as targeted 
gene silencing could be a perfect tool for identifying gene function and use as a 
therapeutic agent (Scherer L et al., 2004).  
 
Following the silencing of ATF5 in them, the ADSCs were exposed to two different 
concentrations of induction cocktails, a sub-optimal concentration (0.1X) and the optimal 
concentration (1X), for a period of five days, during which cells were harvested at three 
different points, the total RNA extracted and analyzed for the expression of ATF5, 
osteocalcin and ATF4 genes. Osteocalcin, being one of the earliest and most specific 
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markers for osteogenesis, would seem like the most appropriate gene to undergo variable 
expression during these initial stages of osteogenic differentiation. Cells that travel down 
the osteogenic lineage would show an elevated expression of osteocalcin. On the 
contrary, cells that do not move along this lineage would not be showing an increased 
expression. ATF4 on the other has been considered to be one of the genes that influence 
osteogenic differentiation in non-bone cells (Yang X et al., 2004a). Its structural 
homology with ATF5 could also imply that these two sets of transcription factors may 
interact during the process of osteogenic differentiation in ADSCs. Therefore, the 
expression pattern for ATF4 could give an indication of the extent of interplay between 
ATF4 and ATF5 in ADSCs subjected to osteogenic differentiation. A short time frame of 
5 days for the study was chosen based on the presumption that ATF5 would have its role 
during the early stages of differentiation, when ADSCs would be committing themselves 
to the osteogenic lineage.   
 
Traditionally the optimal expression of markers for osteogenesis occurs at an induction 
factor concentration of 1X. The logic of using the 0.1X concentration along with the 1X 
concentration were to see if any changes in osteocalcin expression could be picked up 
even at these sub-optimal induction conditions.  
 
If ATF5 indeed suppresses osteogenic differentiation in ADSCs, silencing of ATF5 gene 
should be able to promote osteogenesis and hence an early expression of osteocalcin 
would be seen; while in the non-silenced control groups, such an effect would not be 
seen. Also if ATF4 and ATF5 have a reciprocal role in modulating osteogenic 
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differentiation, one would expect to see a rise in ATF4 expression when the ATF5 gene is 
silenced.  
 
5.2 MATERIALS AND METHODS 
 
5.2.1 Cell Culture  
ADSCs were cultured as previously mentioned. Once the cells reached confluence, they 
were trypsinised and counted. The cells were subsequently plated in 6-well plates at a 
density of 100,000 cells per well in 2.5ml of plating medium. When the cells reached a 
confluence of 50 to 70 %, they were transfected.  
 
5.2.2 Transfection of ATF5 Stealth™ RNAi into ADSCs 
Transfection of the ATF5 Stealth™ RNAi was done based on the protocols provided by 
the company on their website (www.invitrogen.com). The RNAi was delivered into the 
cells using Lipofectamine™ RNAiMAX Transefection Reagent (Invitrogen). For 
transfecting MSCs, the protocol of Forward Transfection was used, whereby 
Lipofectamine – RNAi complexes were prepared and added to cells plated the previous 
day. Briefly about 100,000 ADSCs were plated into each well of a 6-well plate in about 
2500 µl of DMEM without serum or antibiotics. The cells were 30% to 50% confluent 
when transfected.  
The following day, the RNAi duplex-Lipofectamine™ RNAiMAX were prepared. 
Initially about 30 pmol of the RNAi duplex was diluted in about 250 µl of Opti-MEM® I 
Reduced Serum Medium (Invitrogen) without any added serum and mixed gently in a 50 
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ml Falcon tube. In a separate tube, about 5 µl of the Lipofectamine™ RNAiMAX 
Reagent was diluted in 250 µl of Opti-MEM® I Reduced Serum Medium and mixed. The 
contents of both the tubes were mixed gently and incubated at room temperature for 20 
minutes. At the end of this time, the mixture was added to each well, giving a final 
volume of 3000 µl and a final RNAi concentration of 10 nM. The cells were incubated at 
37 º C in 5% CO2.  The first media was changed after 12 hours and subsequently replaced 
every 72 hours.  Appropriate negative controls are used during each time point. Negative 
controls are gene sequences used during transfection studies to look for any non-specific 
effects on gene expression. They are siRNA sequences that do not target any gene 
product and are essential for determining siRNA delivery efficiency. When cells are 
transfected with these sequences there should not be any effects on gene expression 
(www.ambion.com).  
 
5.2.3 Osteogenic Induction 
Following the transfection of the ADSCs with the Lipofectamine – RNAiMAX duplex, 
the cells were induced with standard osteogenic media at two different concentrations: 
1X (optimal induction concentration) and 0.1X (sub-optimal induction concentration). As 
control, uninduced cells treated without any osteogenic induction supplements (i.e. 0X 







5.2.4 RNA isolation and Real-time PCR analysis of ADSCs 
The RNA isolation and real-time PCR analysis was done as mentioned in the previous 
chapter. Following reverse transcription and cDNA synthesis, real-time PCR was done to 
detect ATF5, Osteocalcin, ß-actin and ATF4 genes. Standards for the ATF4 and ATF5 
genes were prepared as per the techniques outlined in the previous chapter. The primer 
sequences used were: 
 
Gene Primer Sequence 
ATF 4 5’-TGACCACGTTGGATGACACT-3’ 
5’-CCTGGTCGGGTTTTGTTAAA-3’ 
ATF 5 5’-GTATTGACCTCCTGGCCTCA-3’ 
5’-CCTTCATTCCAACCCCTCT-3’ 
Osteocalcin 5’-TGTGGCATCCACGAAACTAC-3’   
5’-GGAGCAATGATCTTGATCTTCA-3’ 
ß-Actin  5’-TGTGGCATCCACGAAACTAC-3’ 
5’-GGAGCAATGATCTTGATCTTCA-3’ 
 
Table 5.1 – Primer sequence of genes used for real time PCR in gene silencing                  










5.3.1 Expression of ATF4 during osteogenic differentiation in ADSCs 
Real time PCR analysis of ADSCs for ATF4 gene expression revealed that the pattern 
was variable from donor to donor. In three out of the ten samples analyzed, the 
expression pattern was similar to that seen in human fetal osteoblasts (hFOBs). The 
similarities in pattern of these samples to the expression in hFOBs suggest that these 




Fig 5.1 – ATF4 expression pattern in ADSCs. In three of the ten samples tested, the 
ATF4 expression increased during the second day and dropped drastically by the twenty-
eight day. This pattern was similar to that seen with hFOBs cell lines. The lack of a 
consistent response in all the ADSC samples may be due to the differences in the 



























































5.3.2 Silencing of ATF5 expression by Stealth™ RNAiMAX in ADSCs 
The real time PCR analysis of the ADSCs showed that in all the four patient samples, the 
ATF5 expression was lower in the groups that had been transfected with the RNAi 
duplex complexes (Figs 5.2), indicating that the transfection was effective in silencing the 
ATF5 gene expression. However a significant drop in the expression was not seen across 
all the samples. The expression of ATF5 in the non-silenced samples also followed such 
a trend. Fig 5.2A shows a sample in which significant drop in ATF5 expression after 
silencing was seen only in day 1 at one time point (indicated with the arrowhead) and in 
day 5 at two time points. On the contrary, Fig 5.2 B shows a sample in which significant 
drop in ATF5 expression was seen across all the time points.  
 
In order to negate any discrepancy from cell numbers, in all the donor samples the ATF5 
copy numbers were normalized against β-actin copy numbers for the specific time points.  




















                                                                 










                                                              Fig 5.2 B 
 
 
Fig 5.2 - ATF5 expression normalized to ß-actin. In all the donor samples tested there 
was a decreased expression of ATF5 in the gene silenced groups (Ri + ). The time point 
at which silencing was maximum varied from sample to sample, with some having a 
pronounced response at day 1, while others having at day 2. (A representative graph of 
two donor samples are being shown in Fig 5.2 A and B). 
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5.3.3 Osteocalcin expression in the ADSCs 
Osteocalcin expression in the ADSCs that have been silenced with ATF5 RNAi showed a 
variable expression (Figs 5.3). However, in all of them there was a consistently 
significant difference in the expression levels of the Day 2 samples. The day 2 uninduced 
and gene silenced groups (Day 2 Ri+ subgroups) showed a significantly higher 
expression than the corresponding uninduced and non-silenced groups (Day 2 Ri- 
subgroups). Among the same set of samples, the osteocalcin levels were also found to be 
significantly higher in the gene silenced that were either sub optimally induced (0.1X) 























                                                                             
 
 

































                                                                            Fig 5.3 C 
 
Fig 5.3 - Osteocalcin expression normalized to ß-actin. There were significant increases in the expression 
levels of osteocalcin in the gene silenced groups at varying time points (Ri + subgroups). All the samples 
showed increased expressions, at different time points, in the sub optimally induced (0.1X Ri +) and 
uninduced (0X Ri +) groups which were gene silenced. The arrow heads show the relevant time points at 
which significant differences were seen. 
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5.3.4 ATF4 expression in the ADSCs 
The ATF4 expression did not show the consistent changes seen with osteocalcin, 
indicating that the expression patterns of ATF4 was highly variable. In a few of the 
samples, a significantly increased expression of ATF4 was seen in the ATF5 gene-
silenced groups at day 2 (Fig 5.4B). However, in three of the four samples, the optimally 
induced and ATF5 silenced groups (1X) showed a significant increase in ATF4 compared 



















Fig 5.4 A 
                                                               Fig 5.4 B 
                                                              
Fig 5.4 - ATF4 expression normalized to ß-actin. Some of the ADSC samples showed 
an increased expression of ATF4 in the ATF5 silenced groups (arrow headed groups in 
Figs 5.4 A and B). However the significance was not observed across all the donor 
samples (data not shown). 
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ADSCs are being extensively studied for the purpose of cell replacement therapy. One 
such area wherein there is much scope and potential for cell regeneration therapies is 
bone tissue engineering. ADSCs have been shown to be able to differentiate towards cells 
of the osteogenic lineage when exposed to right set of stimuli (Zuk et al., 2000). 
However, the basic biology that governs the ability of these non-bone origin 
mesenchymal cells to form bone tissue has yet to be clearly outlined. One of the genes 
that is shown to have the potential to modulate this behavior in non-bone cells, as 
mentioned earlier, is ATF4. 
 
To this end, we decided to look for the expression pattern of ATF4 gene in ADSC, both 
before and during induction for a period of 28 days. From our results, we were able to see 
that three out of ten patient samples analyzed for this gene, showed a pattern similar to 
that seen in human osteoblast cell lines (Fig 3.1). The gene levels increased significantly 
by the second day of induction and fell drastically by day twenty eight. As mentioned 
earlier ATF4 has been shown to interact with Runx2 in activating osteocalcin expression 
(Xiao G et al., 2005). Since Runx2 is one of the earliest markers to be elevated during the 
process of osteogenesis, the expression pattern where ATF4 peaks early and falls down 
later on would fall in line with the argument that ADSCs undergoing osteogenic 
differentiation may be influenced by ATF4 in adopting the osteogenic lineage. However, 
this gene may not alone be enough in influencing osteogenesis in ADSCs, as seen by the 




The RNA interference mediated silencing of ADSCs showed that there was a significant 
drop in expression of ATF5 gene in the ADSCs (Fig 3.2 A and B). The fall in expression 
was more pronounced at day 2 and day 5 time points of the study. The absence of a 
significant drop in expression among the Negative control groups (NC) for each of the 
ADSCs in Figs 3.2 indicates that the silencing was effective. 
 
The osteocalcin expression in these ATF5 silenced ADSCs followed an interesting 
pattern. As could be seen from Figs 3.3, in all the ADSC samples, there was a 
significantly elevated expression of osteocalcin in the silenced groups (Ri+ group) at day 
two and five compared to the unsilenced group (Ri – group). The conventional protocols 
for osteogenic induction advice an optimum induction factor concentration of 1X to 
achieve the most efficient osteogenic outcome. In our study, in a few of the ADSC 
samples (Figs 3.3) the osteocalcin was expressed significantly at even the suboptimal 
inducing concentration of 0.1X. In all the ADSC samples, at all time points, there was a 
significant expression of osteocalcin even in the absence of inducing factors (0X 
subgroups in Figs 3.3). While in a few of the ADSC samples this pattern was more 
pronounced at day 5 (Day 5 Ri + 0X subgroups in Fig 3.3), in a few of the same and the 
remaining it was more pronounced at day 2 (Day 2 Ri + 0X subgroups in Figs 3.3).  
 
The ATF4 expression on the other hand, was not very consistent in the tested ADSC 
samples. The normalized ratio of ATF4 to β-actin showed that there was increased 
expression of ATF4 in the ATF5 silenced and subopitmally induced / uninduced groups 
(Ri +and 0.1X / 1X) at varying time points (Figs 3.4). In some of the samples this 
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difference were more pronounced in the Ri + 0.1X / 1X subgroups at day 1, while in 
others it was seen in the same subgroups at either day 2 or 5.  
However a significant over expression of ATF4 in the ATF5 silenced subgroups was seen 
only with ADSC 3 (Fig 3.4 B) where ATF4 was higher in the day 2 ATF5 silenced and 
uninduced group (Day 2 Ri + 0X). 
 
Osteocalcin has traditionally been considered as one of the most specific markers for 
osteogenic differentiation (Ducy P et al., 2000). These expression patterns of osteocalcin 
seen in our study, especially the groups in which there were no induction factors present 
(0X subgroups) indicate that silencing the expression of ATF5 maybe sufficient in some 
cases to trigger osteocalcin expression. A possible explanation for this observed 
phenomenon could be that repression of ATF5 triggers some alternate pathway or 
activates transcription factors that could act to increase osteocalcin expression. At this 
point, however the same could not be said about ATF4. Though one would have expected 
a consistent over expression of ATF4 in an ATF5 silenced situation, the lack of a 
consistent and significant pattern in this study might mean that ATF4 and ATF5 might 
not have mutually reciprocal roles in modulating osteogenesis in ADSCs. On the 
contrary, ATF4 – ATF5 interaction might not have been consistently picked up due to the 
genetic variability in the samples being analyzed. The donor variability that account for 
varying patterns of gene expression as explained in Chapter 4 could be operational here 
as well.  The preliminary ATF4 expression done on the same set of samples done for the 
gene chip analysis during the PhD work of Leong TWD also showed this variability in 
ATF4 expression (Fig 3.1). This may be attributed to the possibility that ADSCs from 
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different human beings differ in their  ‘intrinsic osteogenic potential’ i.e. some of the 
ADSCs are better at responding to osteogenic stimuli in the environment and hence 
undergoing osteogenic differentiation, while others may not be that good at the same. 
Such a variability occurring here could not also be completely ruled out.  
 
5.5 CONCLUSION 
From this study using RNAi against ATF5, it was shown that ATF5 gene could be 
effectively silenced in ADSCs. The expression pattern of osteocalcin among the silenced 
ADSCs demonstrated that in most of the samples tested, ATF5 silencing was enough to 
cause a significant over expression of osteocalcin. However, the same could not be said 
about ATF4. While there was an increased expression of ATF4 in most of the ATF5 
silenced groups which were either sub optimally induced (0.1X) or uninduced (0X), a 
statistically significant result was seen in only one of the four ADSC samples tested. 
However this phenomenon could be due to the differences in the ‘intrinsic osteogenic 
capability’ of the ADSCs tested. Therefore, it may be possible that ATF4 and ATF5 
might interact by themselves or through some other mediators, in inducing osteogenesis 











CO-TRANSFECTION AND EXPRESSION OF ATF4 AND ATF5 IN HEK CELLS 
 
6.1 INTRODUCTION 
One of the genes that have been implicated in inducing osteogenic differentiation in non-
osteoblast cells is ATF4 (Activating Transcription Factor 4). Though the gene for this 
protein is ubiquitously expressed in a wide variety of tissues like brain, thymus, liver and 
the lung, the protein is only expressed in mature osteoblasts (Yang X et al., 2004). When 
NIH3T3 fibroblasts, which in the native state do not express ATF4 protein were 
transfected with siRNA to a ubiquitin ligase that normally cleaves the ATF4 protein in 
non-osteoblast cells, they began to express ATF4 and osteocalcin. These were conclusive 
evidences for the role of ATF4 in mediating osteogenic differentiation in non-osteoblast 
cells. Members of the ATF family have been well known to interact with each other 
forming homodimers and heterodimers. Some of these interactions are the key processes 
that mediate important cellular functions (Ameri K et al., 2007). The interaction of ATF4 
with Runx2 has been shown to increase the expression of osteocalcin gene in non-
osteoblast cell lines (Xiao G et al., 2005). Deletion analysis studies have shown that this 
interaction occurs primarily through the leucine zipper region of ATF4. 
Thus it could be inferred that interactions between key transcription factors like ATF4, 
Runx2 etc. play a significant role in deciding the fate and phenotype of immature cells.  
From the previous chapter it was shown that silencing the expression of ATF5 mRNA 
causes a significant increase in the expression of osteocalcin. While in some of the ADSC 
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sample studied this occurs at suboptimal induction doses (0.1X subgroup), in a few of 
them a significant expression is seen even in the absence of any induction factors (0X 
subgroup). The rise in osteocalcin levels in the absence of induction factors imply that 
silencing of ATF5 in some way triggers some repressed pathways that would not have 
otherwise lead to osteocalcin expression. Similarly, it was also seen that in some of the 
ADSC samples, there was an increased mRNA expression of ATF4 when ATF5 gene had 
been silenced, though a significant difference in expression was seen in only one of the 
four ADSC samples tested. This lack of a significant expression of ATF4 in the other 
three samples might be because of their differences in their intrinsic potential of 
undergoing osteogenic differentiation.  
Based on the well known fact that members of the ATF family have the potential to 
interact among themselves as well as with transcription factors of other groups and the 
inverse gene expression profile of ATF4 and ATF5 that was saw in the gene silencing 
experiments, it was decided to explore the possibility that ATF4 and ATF5 may also have 
the potential to interact with each. In such an eventuality, the interaction between ATF4 
and ATF5 may in some influence the osteogenic differentiation potential of ADSCs.  
 
In order to look for the possibility of a binding potential between ATF4 and ATF5, 
Human Embryonic Kidney (HEK) cell lines were cotransfected with plasmids cloned 
with ATF4 and ATF5 genes. Subsequent to the co-transfection, the cells were lysed and 
the total protein isolated. Following this, co-immunoprecipitation was done on the cell 
lysates. In this procedure, the antibody against one of the proteins (e.g. anti ATF5) was 
used to pull down the proteins from the lysate and subsequently immunoblotted with the 
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antibody against the second (e.g. anti ATF4). If ATF4 and ATF5 are indeed capable of 
binding with each other, such a pull down with using one antibody, should bring along 
with it its binding partner, which could then be detected by the second antibody.  
 
6.1.1 Characteristics of the Vector used for generating plasmid 
The vector used for the initial cloning of the inserts and the subsequent transfection of the 
HEK cell lines was the pCDNA6/His™ A vector (Invitrogen). This is a 5.2 kb vector that 
has been widely used for the transient and stable over expression of proteins in 
mammalian systems. Like most mammalian vectors, this vector possesses a Human 
Cytomegalovirus immediate-early (CMV) promoter, designed for high level protein 
expression in mammalian cell lines. Apart from the CMV promoter, the vector possesses 
an Ampicillin resistance gene for selecting clones in bacteria, Blasticidin resistance gene 
for selection of stable cell lines and a Multiple cloning site with a 6X Histidine Tag 





















Fig 6.2 – Multiple Cloning Site (MCS) of pcDNA6/His™ A (www.invitrogen.com) 
 
6.2 MATERIALS AND METHODS 
6.2.1 Vector cloning and preparation 
The initial cloning of pCDNA6/His™ A vector was done in Novablue™ ( Novagen ) DH 
3α cells. Briefly, the transformation was done by adding about 10 ng of the vector to 20 
µl of Novablue™ cells in a microfuge tube and placing on ice for 5 minutes. At the end 
of 5 minutes, the tube was subjected to heat shock by placing in a water bath preheated to 
a temperature of 42º C for exactly 30 seconds and then again placed on ice for 2 minutes. 
At the end of the time the Novablue™ cells were plated onto an agar plate, containing 
ampicillin at a working concentration of 50 µg/ml and kept for transformation overnight 
at a temperature of 37º C. The following day , a few colonies were picked and grown in 5 
ml of LB medium (Luria Bertani) for 12 to 16 hours in a rotating shaker at a speed of 240 
rpm and temperature of 37º C . The tubes containing the culture media were then spun 
down and the plasmids extracted using a GeneJet™ Plasmid Miniprep Kit (Fermenatas).  
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6.2.2 Insert design and preparation 
Two different inserts were designed and prepared for the purpose of cloning and 
expression.  
 
1. ATF 5 full length – Having the entire 849 base pair corresponding to the coding 
  sequence of the gene. 
2. ATF 4 full length – Having the entire 1056 base pair corresponding to the coding 
 sequence of the gene.  
 
For the process of cloning the inserts into the vectors, EcoR1 and Xho1 (Fermentas) 
were the restriction enzymes chosen. The choices of these two enzymes were based on 
the following reasons: 
1. By choosing two different enzymes for digestion and thus performing a double 
digestion, it would be possible to generate two different sticky ends, and thus 
perform a Directional cloning, thereby ensuring that the insert and vectors would 
ligate only in the proper orientation.  
2. The two enzymes are compatible for double digestion with a common buffer – 
Buffer B (Fermentas). 
The inserts were generated from Human MGC (Mammalian Gene Collection) cDNA 
clones for ATF4 and ATF5 (Open Biosystems Inc.) by Polymerase Chain Reaction 
(PCR). 
The primers for generating the inserts from the mammalian cDNA were designed 
incorporating the restriction sites for EcoR1 and Xho1 into them, so that the PCR 
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products would have these sites. A subsequent digestion of the inserts with these enzymes 
would yield products with sticky ends that would bind to the appropriate sites in the 
vector digested with the same enzymes. The primer sequences for the different inserts 
were: 
 
Table 6.1 – Sequences used for generation of inserts  
 
In order to decrease the incidence of mutations in the cloned inserts, PCR reactions were 
done using high fidelity Pfu Polymerase enzyme (Fermentas). The thermocycling 
conditions were:  
Initial denaturation at 94º C for 5 minutes followed by 35 cycles of denaturation at 94º C 
for 1 minute, annealing at 55º C for 1 minute, extension at 72º C for 2 minutes and a final 
extension at 72º C for 6 minutes. The PCR products were then verified for the size of the 





Insert Primer Sequence 
ATF 5 Full length EcoR1   GCTAAGAATTCATGTCACTCCTGGCGA 
 
Xho1    AATAACTCGAGCTAGCAGCTACGGGT 




6.2.3 Restriction enzyme digestion of the vector and inserts 
Both the vector and the inserts were digested using EcoR1 and Xho1 restriction enzymes. 
As mentioned earlier, since the inserts had the restriction sites for each of these enzymes 
incorporated into them during the subcloing process, digestion would yield products that 
would fit into the vector in the proper alignment. To carry out the enzyme digestion, the 
following components were assembled in a PCR tube: 5 µg of the vector or insert, 20 µl 
of 10X Buffer Tango™ (Fermentas), 10 µl of EcoR1, 10 µl of Xho1 and finally 
deionized water was added to reach a final reaction volume of 100 µl. The reaction 
mixture was then incubated at 37º C for 16 hours in a thermocycler. At the end of 16 
hours the enzymes were inactivated by heating at 80º C for 20 minutes. As control, 
reaction mixture having only the vector or inserts without adding any of the restriction 
enzymes were used. Since the chances of re-ligation of the vector were minimized by 
using two different restriction enzymes, Calf Intestinal Alkaline Phosphatase was not 
used following digestion.  
 
Following digestion of the vector, the cut vector was run against the uncut vector on a 1% 
agarose gel. Since the cut vector becomes linear, it migrates at a different rate when 
compared with the uncut vector. This distinguishes between the two different sets of 
vectors. Once the band of interest (the completely cut vector) was identified in the gel, it 
is cut with a clean razor blade and transferred to a microfuge tube. The digested vector 
was then isolated from the agarose gel by using Gel purification kit ( vCellScience )  and 




The digested inserts were not gel purified; rather they were purified using Qiagen PCR 
purification kits. The purified inserts were then run on 1% agarose gel, to ascertain the 
quality of the purified products. 
 
6.2.4 Cloning of the inserts into the vector 
6.2.4.a  Ligation 
Following purification of the digested vector and inserts, the quantity of each were 
measured for the next step of ligation. The two components were ligated in a molar ratio 
of 1:4 of vector: insert DNA. The calculation was obtained based on the following 
formula: 
ng of vector  x      kb size of insert        x    molar ratio of insert  =  ng of the insert 
                            kb size of the vector                                  vector 
 
Based on the above formula for a ligation reaction using 100 ng of the vector, the 
required molar concentration of the insert comes to around 50 ng .  
 
The final ligation mixture consisted of 100 ng of the vector DNA, 50 ng of the insert 
DNA, 2 µl of 10 X T4 DNA Ligase buffer, 1 µl of T4 DNA Ligase ( Fermentas) and 
water, added to reach a final reaction volume of 20 µl. The reaction mixture was 
incubated at 25º C for 4 hours. At the end of the reaction, no heat inactivation was 
performed. Roughly 2 µl of the ligation mixture was used for transforming about 20 µl of 





6.2.4.b Transformation  
The transformation was done in competent NovaBlue™ E. coli cells. These are a 
commercial variety of DH3 α cells. These cells are the usual hosts of choice for the 
primary cloning of the target plasmid, as they have high transformation efficiency and 
yield large quantities of high quality DNA. These cells lack the gene coding for the T 7 
RNA polymerase and hence cannot be used under expression conditions.  
 
For the purpose of transformation, about 20 µl of frozen competent cells in a microfuge 
tube were allowed to thaw on ice for about 2 – 5 minutes. Following this, about 2 µl of 
the ligation mixture (containing less than 10 ng of DNA) was added to the cells and 
gently stirred. The mixture was the immediately placed on ice and incubated for 5 
minutes. Subsequently the tubes was placed for exactly 30 seconds in a water bath at 42º 
C and then placed back in ice for 2 minutes. This heat shock protocol would ensure that 
the bacterial walls become permeabilized for the uptake of the added DNA.  At the end of 
this procedure the transformation mixture was plated into a pool of about 40 µl SOC 
medium and then spread evenly on the surface of an agar plate containing ampicillin at a 
working concentration of 50 µg/ml. The plates were incubated overnight at 37º C and 
subsequently checked for the presence of positive colonies. As a control, plating was 
done using untransformed competent cells, which technically should not form colonies as 
they do not possess the ampicillin resistance gene contained in the pCDNA6/His™ A 





6.2.4.c Screening for positive recombinants by Colony PCR  
Following an overnight incubation of the transformed mixture, colonies would appear if 
the transformation was successful. Although most of the colonies that appear on the 
plates are those that arise from recombinants, a few may be the outcome of a few uncut 
pCDNA6/His™ A plasmids, which would have escaped the purification process, getting 
transformed into the competent cells. In order to verify the true identity of the positive 
colonies, they are screened for the inserts by direct colony PCR of the colonies, using 
vector specific primers. The primers used for this purpose are the T 7 Promoter Primer 
and the BGH reverse Primer. These primers amplify the region between the promoter and 
terminator regions and by running an agarose gel on the PCR reaction mixture, the size of 
the inserts can be assessed. The sequence of the primers, are as follows (obtained from 
www.invitrogen.com ):  
T7 Terminator Primer    5'-GCTAGTTATTGCTCAGCGG-3'   
BGH reverse Primer    5’- TAGAAGGCACAGTCGAGG-3’ 
   
Briefly, a colony was picked from the primary transformation plate using a micropipette 
tip and placed in a tube containing 14 µl of sterile deionized water. A PCR master mix 
with the following composition was made for the colony PCR: 2 ml of 10 X Taq buffer, 
1.5 ml of MgCl2 ,  0.5 µl of Taq Polymerase enzyme, 1 µl of 20mM dNTP mix, 0.5 µl of 
5mM T 7 promoter primer, 0.5 µl of 5mM T 7 terminator primer. The cycling conditions 
were – 94º C initial denaturation for 5 minutes , followed by 35 cycles of denaturation at 
94º C for 1 minute, annealing at 55º C for 1 min, extension at 72º C for 2 minutes and a 
final extension phase at 72º C for 6 minutes. At the end of the reaction, about 15 µl of the 
reaction mixture was loaded into the wells of a 1% agarose gel and run against a DNA 
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ladder. As a control, the colony PCR reaction was done on the uncut pCDNA6/His™A 
plasmid. The size of the prominent band would correspond to the total region between the 
primers.  
 
Once the correct identities of the colonies were established by colony PCR, those 
colonies that contained the insert were then grown in a 5 ml tube containing LB medium 
by incubating at 37º C for 12 to 16 hours in a shaker at a speed of 240 rpm. The plasmids 
were then extracted and purified from the 5 ml broth using a GeneJet™ Plasmid 
Miniprep kit.  The plasmids were then sequenced in an ABI sequencing machine with 
pGEM vector as the control. The results were analyzed on Chromas Lite™ software. The 
alignment of reading frames and absence of mutations was confirmed. 
 
6.2.5 Estimating the molecular weight of the proteins to be expressed  
The molecular weights of the proteins being expressed were based on the sum of the total 
number of bases of the cloned insert plus the additional bases between the start codon of 
the vector and the point of insertion of the insert within the MCS. Based on the vector 
map (Fig 4.2), the number of additional bases between the start codon (ATG) and the 
EcoR1 site is exactly 115 bp. The total base pair lengths of ATF4 and ATF5 are 1056 and 
849 bp respectively. Adding the extra bases, ATF4 mRNA would have a total length of 
1171 bp, equivalent to 390 amino acid sequences and ATF5 mRNA would have total 
length of 964 bp, being equivalent to 321 amino acid sequences. From the assumption 
that the average molecular weight of a single amino acid is 0.1 kD, the expected 
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molecular weight of our expressed products would be 39 kD for ATF4 and 32 kD for 
ATF5.  
 
6.2.6 Co-Transfection of ATF4 and ATF5 plasmids into HEK293 cells 
The colonies that generated plasmids having the right sequence of the cloned genes were 
then grown in large numbers for plasmid isolation. Parallel to this, HEK 293 cells were 
grown in and maintained in DMEM supplemented with 10% Fetal Bovine Serum 
(Gibco). The protocol used for transfection was optimized based on the guidelines given 
by the company (Invitrogen).  
 
A few days before the transfection procedure, the HEK cells in culture were trypsinized 
and counted. They were subsequently plated as a lower density in 100 mm culture dishes 
(TPP plastics), so that on the day of the transfection, they would be 60% to 80% 
confluent. The cells were maintained in DMEM supplemented with 10% FBS, without 
the use of any antibiotics. On the day of the transfection about 2 µg each of ATF4 and 
ATF5 plasmids were diluted in 750 µl of DMEM, without any supplemented FBS in a 50 
ml Falcon tube. To this mixture about 20 µl of Plus reagent™ (Invitrogen) was added and 
incubated at room temperature for 20 minutes. Plus reagent™ is a proprietary transfection 
enhancing agent, which is supposed to increase the transfection efficiency. In a separate 
Falcon tube, 30 µl of Lipofectamine™ Reagent (Invitrogen Catalog : 18324-012) was 
diluted in 750 µl of DMEM without serum. At the end of 20 minutes of incubation, the 
plasmid–Plus reagent™ complex was mixed with the Lipofectamine™ reagent and 
further incubated for 20 minutes. While the complexes were being formed, the media on 
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the plates were replaced with 5000 µl of DMEM supplemented with 10% FBS. At the 
end of the incubation period, the complexes were added onto the 100 mm culture dishes 
to reach a final volume of 6500 µl. The culture dishes were maintained in an incubator at 
37º C in 5% CO2 for 5 hours, at the end of which the media in each plate were topped up 
to 10 ml. The transfected cells were maintained in the incubator for 48 hours, to achieve 
the optimal protein expression. As control, untransfected HEK cells were grown and 
maintained in similar conditions for the required time frame.  
 
6.2.7 Immunoprecipitation of ATF4 and ATF5 from HEK cell lysates  
After 48 hours, the cells were lysed in 1% Nonidet P-40 Lysis buffer. The buffer is 
composed of 50 mM Tris-HCl (pH 7.4), 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA, 
1 mM NaF, 1 mM Phenylmethylsulfonyl fluoride, 1 mM Na3VO4 and 100X Protease 
Inhibitor. The cells were lysed at 4º C for 20 minutes and the lysate collected. 
   
For immunoprecipitation, the supernatants were mixed with 40 µl of Immobilized Protein 
G Plus beads (Catalog No: 22851, Pierce) at room temperature for 1 hour and then 
centrifuged at 14,000 rpm for 2 minutes. The precipitated beads were discarded and the 
total protein concentration estimated in the cell lysates. For each immunoprecipitation 
about 1000 µg of the total protein was incubated with 3 µg of the respective antibody 
overnight at 4º C on a rocker. The following day, the immunoprecipitates were collected 
by adding 40 µl of the Immobilized Protein G Plus beads and incubation for 1 hour at 
room temperature. The immunoprecipitate-Protein G bead complex was collected by 
centrifuging at 14,000 rpm for 2 minutes. The precipitates were subsequently washed five 
times in cold PBS. The beads with the protein complexes were treated with 20 µl of SDS 
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buffer (with added ß-mercaptoethanol) and denatured by heating at 90º C for 10 minutes. 
The proteins were then resolved by SDS-Page and transferred to nitrocellulose 
membrane. Western blot was done with the corresponding antibodies.  
Primary antibodies used for the detection of the respective proteins were:  
 
 Rabbit anti human ATF4 (Abcam, ab23760)  - 1:1000 
 Goat anti human ATF5 (Abcam, ab1370)  - 1:2000 
 
For ATF4 detection, the secondary antibody used was anti-Rabbit antibody conjugated to 
HRP (Horse radish peroxidase) enzyme, raised in goat (Zymed, 62-6120), used at a 
concentration of 1:15,000. For ATF5 detection, the secondary antibody used was anti-















6.3.1 Insert preparation  
The inserts after PCR were run on a 2% gel and the product lengths verified. From Fig 
6.3 A and B, it can be seen that the size of the inserts corresponded to those predicted 
from the initial calculation. ATF4 inserts corresponded to a product size of around 1050 
bp (1056 bp – actual length) and the ATF5 inserts corresponded to a size of around 900 











Fig 6.3 – Gel picture of the inserts obtained from PCR. ATF4 (Fig 6.3 A) corresponds 
to the 1050 bp marker, while ATF5 corresponds to 900 bp marker (Fig 6.3 B). Running 
the two inserts on the same gel gave a clearer distinction between the two (Fig 6.3 C). 









6.3.2 RE cut and uncut vector 
The vector after double digestion was run on a gel. The cut vector, being linear, ran at a 
slower pace (Fig 6.4, red boundary) when compared to the uncut vector (Fig 6.4, 
turquoise boundary), which was supercoiled. This was the basis of delineating separating 








Fig 6.4 – Gel picture of the vector after Restriction Enzyme digestion. The uncut 
vector (turquoise box) having a weight of 5200 bp, being supercoiled appears to run 
faster than the cut vector (red box). This is because the linear structure of the cut vector 
impedes its paces through the gel, causing it to appear lagging behind the uncut vector.  
 
 
6.3.3 Colony confirmation through Colony PCR 
Colony PCR was done on the transformed colonies to identify those colonies which had 
taken up the correct set of inserts. The estimated product length for the ATF4 inserts 
within the plasmid was around 1100 bp (Fig 6.5 A) and the same for the ATF5 inserts 
were close to 950 bp (Fig 6.5 B). The extra base lengths detected in each of the inserts 
(when compared to the native PCR product above) are the extra bases flanking the insets 









Fig 6.5 – Gel picture of the inserts obtained from colony PCR. ATF4 insert (Fig 6.5 A) within 
the plasmid corresponds to the 1100 bp marker, while ATF5 corresponds to 950 bp marker (Fig 
6.5 B)  
 
6.3.4 Western Blot with Anti-His antibody  
Cell lysates were immunoblotted with anti-His antibody. Three distinct bands were 
observed when the blots were stained (Fig 6.6A). The top most band was seen at a 
molecular weight of around 80 kD, the second one was at around 70 kD, while the most 
prominent came around 65 kD. Similarly single transfection with ATF5 alone was able to 
generate a single band on anti-His treatment (Fig 6.6B). Lysates from untransfected cells 
when treated with anti His antibody were not able to generate any such bands (blue boxes 
in Fig 6.6 A and B). 
 






Fig 6.6 – Anti-His immnuoblotting of the HEK lysates. The lysates obtained from cotransfected cells 
(Fig 6.6A) show three distinct bands at molecular weight 80, 70 and 65 kD. Cell lysates from single 
transfection with ATF5 (Fig 6.6B) show a single band at 65 kD. This can be compared to the lysates from 


















6.3.5 Immunoblotting of the lysates with anti-ATF5 and anti-ATF4 antibodies 
Immunoblotting of the cotransfected lysate with anti-ATF5 antibody was able to show a 
prominent band at 65 kD weight (Fig 6.7A), indicating that the band at 65 kD was indeed 
ATF5 protein. Similarly, immunoblotting with ATF was able to show two such distinct 












Fig 6.7 – Anti-ATF5 and anti-ATF4 immunoblotting of the HEK lysates. The lysates 
obtained from cotransfected cells show a single prominent band at 65 kD when immunoblotted 
with anti-ATF5 antibody (Fig 6.7 A). Immunoblotting of the same blot with anti-ATF4 showed 
two prominent bands at about the same weight (Fig 6.7 B).This is in comparison to untransfected 





















Western with Anti ATF4 
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6.3.6 Immunoprecipitation with anti-ATF4; Western Blot with anti-ATF5 
Immunoprecipitation with anti-ATF4 and subsequent immunoblotting with anti-ATF5 
showed the presence of two distinct bands. The upper band lies at a molecular weight of 







Fig 6.8 – IP with anti-ATF4; WB with anti-ATF5. The immunoblotting with anti-
ATF5 showed the presence of two prominent bands. The heavier band was at molecular 
weight of 65 kD, while the lighter one was at around 32 kD.  
 
6.3.7 Immunoprecipitation with anti-ATF5; Western Blot with anti-ATF4 
Immunoprecipitation of the cell lysates with anti-ATF5 and subsequent immunoblotting 







Fig 6.9 – IP with anti-ATF5; WB with anti-ATF4. The immunoblotting with anti-









Immunoprecipitation is one of the commonly used methods for demonstrating the ability 
of proteins to interact with one another. In this procedure the protein of interest is 
precipitated with Protein G beads initially using specific antibody.  If there are any 
binding partners to this protein, they would also be pulled down by the first antibody and 
could be detected by a second antibody, specific to the binding partner.  
 
To look for any interaction between ATF4 and ATF5, we decided to clone the two genes 
in a mammalian expression vector. The inserts that were generated by PCR from the 
Human MGC (Mammalian Gene Collection) cDNA clones for the respective proteins 
were of the correct base pair length (Fig 6.3 A, B and C). The subsequent transformation 
in Novablue™ cells was successful and we were able to isolate colonies that had taken up 
the right set of inserts (Fig 6.5). The plasmids isolated from these colonies were then 
cotransfected into HEK 293 cells. These cells have been used extensively for in vivo 
transfection and protein expression and have been known to yield consistently good 
transfection and expression efficiencies (Okamoto Y et al., 2005; Sauerwald TM et al., 
2002).  
Western blot done on the cell lysates with anti-His antibody showed three distinct bands 
(Fig 6.6 A). Anti-his antibody is very specific for detecting expressed proteins, as it binds 
to the unique repeats of histidine sequences seen in the expression tag, and thus cannot 
bind to the native histidine residues. The molecular weights detected were around 80 kD, 
70 kD and 65 kD. The subsequent blotting with anti-ATF5 antibody was able to generate 
a band at the 65 kD mark. This implies that ATF5 proteins might be present at the 65 kD 
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mark. This is roughly twice the estimated molecular weight of ATF5, which is around 32 
kD.  A possible explanation for this finding maybe because the ATF5 in the cell lysates 
are being strongly bound to each other, generating a combination of homodimers. Also it 
may be possible that the other two bands seen at 75 kD and 80 kD maybe the outcome of 
such binding in the lysates. With the molecular weight of monomeric ATF4 being 39 kD, 
a homodimeric form could possibly have a molecular weight of around 78 kD (which 
could theoretically correspond to the highest band in Fig 6.6A. Similarly a heterodimer of 
ATF4 and ATF5 would be expected to have a molecular weight of 71 kD (39 + 32). The 
band seen at 75 kD could as well imply a heterodimer of ATF4 and ATF5. Though it 
could be presumed from this that ATF5 is forming dimers in the cell lyste, it would be 
rather premature to assert that the same occurs in vivo in the body. This is because small 
alterations in pH and ionic concentrations of the cell lysates may be enough to alter the 
affinity and binding properties of proteins. Another reason is that in vivo, these proteins 
are being expressed in very minute quantities. Situations like this, where proteins are 
being generated in large quantities, itself maybe enough to influence their binding 
properties. 
 
When immunoprecipitation was done with anti-ATF4 and the pull down immunoblotted 
with anti-ATF5, two distinct bands were generated (Fig 6.8). The heavier band (at a 
molecular weight of 65 kD), corresponded to the one that was observed in Fig 6.6A. 
Along with this, a smaller band between 30 to 35 kD could also be seen. The heavier 
band could be the dimerized form of ATF5, just like the ones seen in the plain cell 
lysates. The smaller band, which was also detected with anti-ATF5 antibody, corresponds 
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to the molecular weight of ATF5 monomer predicted from our calculations (ie around 32 
kD). It could be implied from these findings that immunoprecipitation with anti-ATF4 
antibody was able to pull down with it two distinct bands of ATF5 proteins. The heavier 
band might be the homodimeric form of ATF5, while the lighter band could be the 
monomeric form of ATF5.  
 
In the next phase, where immunoprecipitation was done with anti-ATF5 and western was 
done with anti-ATF4, we were able to pull down a protein having a molecular weight of 
around 35 kD (Fig 6.9). The presence of a single, distinct band being detected with anti-
ATF4 would imply that the protein being detected here is the monomeric form of ATF4 
itself. However, the molecular weight that is being seen here is lesser than that predicted 
for ATF4 (i.e. about 39 kD). This discrepancy may stem from the possibility that ATF4 
protein may have undergone degradation or might have been prematurely cleaved, 
yielding a smaller fragment. At this point, it could be presumed that when ATF5 protein 
is being pulled down from cell lysates, ATF4 would be also be pulled out.  
 
6.8 CONCLUSION 
When immunoprecipitation was done on these cell lysate containing expressed ATF4 and 
ATF5, ATF5 pull down resulted in co-precipitation of ATF4 and vice versa also, 
implying that these two proteins might have the possibility of interacting with each. If 
such a possibility exists, it might mean that this interaction could influence the manner in 
which ADSCs undergo osteogenic differentiation. However, this experiment is fraught 
with a few drawbacks, namely the inability to correctly mimic an in vivo environment. 
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Since this work was done on cell lysates having an abundance of the interacting proteins 
(unlike the physiological situation where these transcription factors are found in very low 
concentrations within the nucleus), it would be premature to arrive at the conclusion of 
the nature of interaction and hence the subsequent effects of these protein interactions. 
Even then, looking at the data from the gene silencing experiments and the cotransfection 
experiments, it could be gathered that ATF5 might have relevance in the osteogenic 





















CONCLUSION AND FUTURE LINE OF WORK 
 
Human adipose tissue is a rich source of stromal cells. This work has shown that adipose 
tissue isolated from lipoaspirates of human donors can be processed to yield a population 
of stromal cells, called ADSCs, having unique properties. These cells when grown in 
cultures exposed to osteogenic stimuli showed markers suggesting commitment towards 
the osteogenic lineage. Alizarin red staining and Immunohistochemistry showed 
significantly visible differences between the osteo-induced and uninduced samples. These 
finding were corroborated by real time PCR which showed an increased expression of 
specific markers like osteocalcin and Runx2 in the osteo-induced groups. However, there 
was considerable variation in the gene expression pattern of osteopontin and osteonectin 
among different donor groups. The expression of the protein form of the above two genes 
gave a variable result in the western blot experiments. As explained in Chapter 4, such an 
inter donor variability in marker expression could be the outcome of several factors like , 
differential sampling techniques or functional differences in the osteogenic potential of 
the MSCs or variations in the physiological status  of the patients.  
 
Previous work done by Leong TWD had shown that one particular gene, known as ATF5, 
was consistently down regulated during osteogenic induction of ADSCs. As a 
continuation of this, the change in gene expression profile of ADSCs to osteogenic 
stimuli when the expression of ATF5 was silenced by RNA interference was observed. It 
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was observed that when ATF5 gene expression is silenced with siRNA, an increased 
expression of osteocalcin was seen in some of the ADSC, even in the absence of any 
inducing factors. The expression of another protein which has been implicated in 
mediating the process of osteogenesis in non-osteoblast cells, known as ATF4 was also 
studied. An increased expression of ATF4 was also seen in some, but not all the samples 
studied, which might be due to the intrinsic differences between the osteogenic 
capabilities of the different cell samples. 
 
The subsequent cotransfection and immunoprecipitation experiments with ATF4 and 
ATF5 proteins showed that these two proteins have the potential to bind to each other. 
However, the shortcomings of these experiments were that they were done with cell 
lysates having proteins expressed in large quantities. The presence of an excess of 
proteins and the different buffering environment could have influenced the extent of 
interaction between the two proteins. Though the binding observed in the in vitro 
expressed proteins was not conclusive enough to prove that such a phenomenon does 
occur in vivo, this further strengthened the hypothesis that binding of ATF4 and ATF5 
may indeed occur and influence the behavior of ADSCs under osteogenic conditions.  
 
A better way of estimating the nature of interactions between transcription factors in vivo 
maybe to look at the nuclear extracts of native cells. However, the lower concentration of 
these factors in the nucleus might also influence the outcome of the experiments. A 
knock out model, in which there is targeted disruption of the genome, would bring about 
the phenotype change that occurs from the absence of protein expression. Profiling the 
92 
 
expression pattern of such a model would reveal those pathways and signals that come 
directly under the influence of the disrupted protein. Similarly, lentivirus mediated stable 
gene suppression would also bring about such an outcome, thus making it possible to 
focus in the right direction.  
 
The findings in this thesis indicate that osteogenic induction of ADSCs is a property that 
varies among donor samples. Apart from the ATF family of proteins, there could be a 
number of other transcription factors that interplay to bring about osteogenesis in 
ADSCs. A clearer understanding of the molecular mechanisms would better identify 
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